{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "365aa9ad",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "my medibot\n"
     ]
    }
   ],
   "source": [
    "print(\"my medibot\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "8952fb2c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'c:\\\\Users\\\\Manodya\\\\Desktop\\\\Bsc.AI\\\\PROJECTS\\\\Medical chatbot\\\\Medical-chat-bot\\\\research'"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "609796bb",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "os.chdir(\"../\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "fc5ebd96",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'c:\\\\Users\\\\Manodya\\\\Desktop\\\\Bsc.AI\\\\PROJECTS\\\\Medical chatbot\\\\Medical-chat-bot'"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "8111fa36",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\tqdm\\auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    }
   ],
   "source": [
    "from langchain.document_loaders import PyPDFLoader,DirectoryLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "ca8b7d54",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 0, 'page_label': '1'}, page_content='Common Skin Disease\\nSurangkana Veeranawin, MD\\nMSc, Queen Mary University of London\\nMmed, University of Sydney\\nDipDerm RCPS(Glas.)\\nDiplomate American Broad of Aesthetic Medicine (ABAM)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 1, 'page_label': '2'}, page_content='Acne Vulgaris\\n\\uf0a4 Inflammatory disorder of pilosebaceous follicle with a 90% \\nprevalence in adolescence and young adulthood.\\n\\uf0a4 History: often asymptomatic lesions (especially comedone), \\nalthough can be tender (nodules)\\n\\uf0a4 Physical: two types of lesions, predominantly affect face, \\nneck, chest and back\\n- Noninflammatory; open(“black head”) and closed (“white \\nhead”) comedones\\n- Inflammatory; papules, pustule, cysts, nodule: deep lesions \\n(leave scars)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 2, 'page_label': '3'}, page_content='Acne Vulgaris\\n\\uf0a4 4 Major components\\n• Abnormal follicular keratinization: follicular wall cells fail to \\ndesquamate to the surface in the normal manner.\\n• Sebum over production secondary to androgen\\n• Propionibacterium acnes infection; they grow in the \\nsebum-cell mixture.\\n\\uf0a7 Inflammation\\n\\uf0a4 Other components; genetic factors, occlusive cosmetic \\nagents, medication (steroids, ACTH, androgens, lithium, \\nantiepileptics, oral contraceptives), diseases (PCOS, \\nCongenital Adrenal Hyperplasia)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 3, 'page_label': '4'}, page_content='Acne\\nTreatment Strategies\\n- Retinoid for clearing pores and comedones for all acne \\nconditions\\n- Small inflammatory lesions \\uf0e0Topical Benzoyl Peroxide (BP) &  \\nTopical Antibiotic\\n- Large inflammatory lesions \\uf0e0 Oral antibiotic'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 4, 'page_label': '5'}, page_content='Acne\\nMild \\uf0e8\\uf0e8 Topical Only\\n\\uf0a4 Decrease follicular plugging\\n• Retinoid \\n• Nightly\\n• Adapalene (Differin); if can not tolerate retinoid\\n• Salycilic acid wash/scrub\\n\\uf0a4 Decrease P. Acne\\n• Topical Antibiotic \\n• Clindamycin  \\n• Benzoyl peroxide; bacterialcidal, decrease sebum/oil'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 5, 'page_label': '6'}, page_content='Acne\\nModerate or nonresponsive to topical\\n\\uf0a4 Add oral antibiotic\\n• Tetracycline\\n250 – 500 mg twice/day\\n• Minocycline \\n50 – 100 mg twice/day\\n• Doxycycline\\n50 – 100 mg twice/day\\n\\uf0a4 Add chemical peel  \\uf0e0 Salicylic or Jessner'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 6, 'page_label': '7'}, page_content='Acne\\n\\uf0a4 Other treatment\\n- comedone extraction, intralesional cortisone injection (for \\npapulonodules, cysts), oral contraceptives (esp. anti-\\nandrogenic such as cyproterone acetate), photodynamic \\ntherapy, spironolactone (reduces androgen production; 50 \\n– 200 mg/day), dermabrasion\\n- Patients should be forewarned of acne exacerbations in \\nthe first month of systemic therapy as deep-seated acne \\ncomes to the surface. Also, systemic therapy can required 6 \\nwk before benefits are noted'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 7, 'page_label': '8'}, page_content='Rosacea\\n\\uf0a4 Chronic vascular & acneiform disorder\\n\\uf0a4 Common chronic inflammatory disorder of pilosebaceous units \\nand vasculature of the face\\n\\uf0a4 Role of Demodex mite controversial\\n\\uf0a4 Increase reactivity of capillaries \\uf0e8\\uf0e8\\uf0e8Flushing\\uf0e8\\uf0e8\\uf0e8ultimately \\nleading to telangiectasia'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 8, 'page_label': '9'}, page_content='Rosacea\\n\\uf0a4 Easy and recurrent flushing\\n\\uf0a4 Sensitive skin\\n\\uf0a4 More common in fair skin\\n\\uf0a4 May complain of dry and gritty eyes\\n\\uf0a4 Female > male\\n\\uf0a4 Peak incidence 30-50 yr'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 9, 'page_label': '10'}, page_content='Rosacea\\nEXACEBATE BY\\n\\uf0a4 Heat,rapid change in temperature\\n\\uf0a4 Sun exposure\\n\\uf0a4 Cold\\n\\uf0a4 EtOh\\n\\uf0a4 Stress\\n\\uf0a4 Spicy food\\n\\uf0a4 Hot food/beverage\\n\\uf0a4 Caffeine'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 10, 'page_label': '11'}, page_content='\\uf0a4 Clinical appearance: Erythema, telangiectases, papules, \\nand pustules of central face; no comedones in contrast \\nto acne.\\n\\uf0a4 Erythema of the nose is highly characteristic of rosacea\\n\\uf0a4 Accompany with, sebaceous hyperplasia, seborrheic\\ndermatits & facial lymphedema more common'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 11, 'page_label': '12'}, page_content='Rosacea\\n\\uf0a4 Predominantly central face\\n- Forehead\\n- Cheeks\\n- Nose\\n- Chin\\n- Occasionally eyelids'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 12, 'page_label': '13'}, page_content='Rosacea\\n\\uf0a4 4 Major subtypes\\n\\uf0a4 Vascular rosacea ( Erythematotelangiectatic rosacea)\\n\\uf0a4 Papulopustular rosacea\\n\\uf0a4 Ocular rosacea: gritty, conjunctival injection, styes and \\nphotophobia. (The eye is involved in about 50% of cases)\\n\\uf0a4 Nasal sebaceous hyperplasia (rhinophyma): chronic \\ninflammation may progress to rhinophyma (more common in \\nmale)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 13, 'page_label': '14'}, page_content='ROSACEA'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 14, 'page_label': '15'}, page_content='ROSACEA\\nRHINOPHYMA\\nPAPULOPUSTULAR'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 15, 'page_label': '16'}, page_content='Rosacea\\n\\uf0a4 Investigation\\n- Clinical diagnosis\\n- Skin biopsy to rule out lupus or sacoidosis\\n\\uf0a4 Differential Diagnosis\\n- Acne              - Lupus erythematosus - Sarcoidosis\\n- Seborrheic dermatitis     - Perioral dermatitis'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 16, 'page_label': '17'}, page_content='Rosacea\\n\\uf07d Management\\n- Based on severity and  subtype.\\n- Lifestyle modification : Avoid triggers ; sun protection & \\navoidance.\\n- Topical antibiotic \\n\\uf096 Metronidazole 0.75% gel or 1% cream bid\\n\\uf096 Sodium sulfacetamide lotion 10% bid\\n\\uf096 Azelaic acid QD'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 17, 'page_label': '18'}, page_content='Rosacea\\n- Oral antibiotic (moderate to severe cases with \\ninflammatory papulopaustular component)\\n\\uf096 Tetracycline 500 mg po BID\\n\\uf096 Minocycline 100 mg OD – BID\\n\\uf096 Doxycyline 20 mg po bid (subantimicrobial dose \\ntherapy) or 100 mg po qd-bid\\n- Isotretinoin and prednisolone for very severe cases'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 18, 'page_label': '19'}, page_content='Rosacea\\n- Light therapy\\n\\uf096 Treatment of Choice \\uf0e0 IPL (400nm – 1200nm), PDL  \\n(595 nm) for telangiectases\\n\\uf096 Ablative laser (CO2) for rhinophyma\\n- Ophthalmologist to assess for ocular involvement \\n(blepharitis, conjunctivitis)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 19, 'page_label': '20'}, page_content='Pityriasis rosea\\n\\uf0a4 Acute, self-limited papulosquamous inflammatory skin \\nexanthem in 15-40 yr.\\n\\uf0a4 The primary lesion is an oval, salmon-colored, 1-10 cm \\nplaque that forms a round collarette of scale in the \\ncenter.\\n\\uf0a4 It evolves rapidly, usually beginning with patch that \\nheralds the eruption, the so-called “herald patch.\\n\\uf0a4 Clinical appearance: Scaly pink-erythematous plaques; \\npredominantly trunk affected, in “Christmas-tree” pattern'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 20, 'page_label': '21'}, page_content='Pityriasis rosea\\n\\uf0a4 Etiology: Possibly triggered by human herpes virus 7\\n\\uf0a4 History: May be pruritic or asymptomatic; preceding URTI or \\nmild constitutional symptoms\\n\\uf0a4 Lesions are found on the trunk and usually spare the face \\nand extremities\\n\\uf0a4 The number of lesions is highly variable. Plaques may extend \\nto the neck and proximal limbs\\n\\uf0a4 Numerous lesions may appear. A concentration of lesions on \\nthe groin and lower abdomen is highly characteristic, \\nespecially in children'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 21, 'page_label': '22'}, page_content='Pityriasis rosea'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 22, 'page_label': '23'}, page_content='Pityriasis rosea\\n\\uf0a4 Course: Self-resolving in 6-8 weeks\\n\\uf0a4 Investigations: Clinical; scraping for KOH (R/O tinea) or \\norder RPR (R/O syphilis), or skin biopsy if uncertain.\\n\\uf0a4 DDx: Eczema, psoriasis, tinea corporis, syphilis, seborrheic\\ndermatitis'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 23, 'page_label': '24'}, page_content='Pityriasis rosea\\n\\uf0a4 Management\\n- Reassurance is key\\n- Symptomatic management of pruritus (e.g. mild topical \\nsteroids, antihistamines); mentholated lotion or sprays for \\nitching\\n- Erythromycin 250 mg, q.i.d or 25-40 mg/kg in four divided \\ndoses in children for 2 weeks may clear the eruption\\n- Light therapy (e.g. UVB) may help hasten resolution and \\nrelieve pruritus'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 24, 'page_label': '25'}, page_content='Lichen Planus\\n\\uf0a4 Acute or chronic inflammatory disorder affecting the skin, \\nscalp hair follicles, mucous membranes, and nails (5%-\\n10%)\\n\\uf0a4 Etiology: Likely an immunologically mediated reaction; \\noral erosive lichen planus associated with hepatitis C \\n(Characteristic eruption of unknown etiology)\\n\\uf0a4 History: Uncommon in children. Family history is 10%. \\nPruritus common; oral lesions may or may not be \\nsymptomatic. Ask about Hep C risk factors (e.g., \\ntransfusions) for oral erosive LP. May be drug-induced.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 25, 'page_label': '26'}, page_content='Lichen Planus\\n\\uf0a4 Physical: 7 P’s\\n- Planar (flat-topped)        - Pruritic (intense)\\n- Purple                                - Polygonal\\n- Papules                             - Penile (commonly affected)\\n- Prolonged course (up to 18 mo; longer in some case)\\n\\uf0a4 Distributed on flexor surfaces, penis (glans), mouth (lacy white \\npatches or erosions – Wickham striae)\\n\\uf0a4 Koebner phenomenon: appearance of lesions at sites of trauma'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 26, 'page_label': '27'}, page_content='Lichen Planus'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 27, 'page_label': '28'}, page_content='Lichen Planus\\n\\uf0a4 Course: May resolve spontaneously or have chronic \\ncourse (esp. oral LP); increase risk of oral SCC in oral LP\\n\\uf0a4 DDx: Drug reaction, Pityriasis rosea, Psoriasis\\n\\uf0a4 Investigations: Skin biopsy if unsure of diagnosis'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 28, 'page_label': '29'}, page_content='Lichen Planus\\n\\uf0a4 Management\\n\\uf0a4 Topical: Mild to high potency steroid bid for 2 weeks; intralesional if \\nhypertrophic/thick. Triamcinolone acetonide in adhesive base for oral lesion\\n\\uf0a4 Systemic: (if severe and generalized)\\n- Prednisolone; a 4 weeks course starting at 1 mg/kg q.d. \\n- Retinoids\\n- UV therapy\\n- Cyclosporine\\n- Metronidazole 500 mg po bid * 6 wk, sedative antihistamines for itching'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 29, 'page_label': '30'}, page_content='Psoriasis\\n\\uf0a4 Common (1%-2% prevalence), chronic, recurrent \\ninflammatory skin disease with unpredictable course.\\n\\uf0a4 Onset: any age, peaks late twenties\\n\\uf0a4 Etiology: Genetic & environment factors; abnormal \\nepidermal differentiation and hyperproliferation initiated \\nand maintained primarily by T-cell\\n\\uf0a4 History: Visible itchy red plaques with increase skin scaling \\nand peeling. May have joint pain (7-20%). May have \\npreceding URTI (Streptococcus infection). Worsened by \\nsmoking, alcohol & stress, physical trauma'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 30, 'page_label': '31'}, page_content='Psoriasis\\n\\uf0a4 Physical: Most common chronic plaque psoriasis. \\nCharacteristic sharply defined, erythematous plaques \\nwith silvery-white scale; distributed over extensor surfaces \\n(elbows, knees), scalp, sacrum and other sites\\n- Nail psoriasis: Pitting, thickening, “oil-drop”, lifting of nail \\nplate off of distal nail bed (onycholysis)\\n- Koebnerization = new lesions occur at sites of skin trauma \\n(as with lichen planus)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 31, 'page_label': '32'}, page_content='Psoriasis\\n\\uf0a4 Variants: Vulgaris, palmoplantar, guttate (may follow \\nstreptococcal pharyngitis), erythrodermic, pustular, \\ninverse (affects folds and flexor surfaces)\\n\\uf0a4 Drug may precipitate or exacerbate psoriasis: \\nAntimalarials, clonidine, indomethacin, iodine, lithium, \\nNSAIDS, quinidine, some beta-blockers, steoids\\nwithdrawal and terfenadine.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 32, 'page_label': '33'}, page_content='Psoriasis (Plaques type)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 33, 'page_label': '34'}, page_content='Psoriasis (Erythroderma)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 34, 'page_label': '35'}, page_content='Psoriasis (Guttate type)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 35, 'page_label': '36'}, page_content='Psoriasis (Palmoplantar)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 36, 'page_label': '37'}, page_content='Psoriasis (Inverse type)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 37, 'page_label': '38'}, page_content='Psoriasis\\n\\uf0a4 In 10-20% may be associated with psoriatic arthritis, most \\ncommonly of the small joints of the hands and feet; \\nrequires systemic Tx\\n\\uf0a4 Investigation: Clinical diagnosis; skin biopsy if uncertain\\n\\uf0a4 DDx: Drug reaction, eczema. Lichen planus, pityriasis\\nrubra pilaris'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 38, 'page_label': '39'}, page_content='Psoriasis\\n\\uf0a4 Topical\\n- Steroids; Fast, temporary relief (atrophy, telangiectasia)\\n- Calcipotriol ointment, 100g bid. on weekdays as \\ntolerated + topical steroid bid., weekends\\n- Tazarotene 0.05%, 0.1% cream qhs\\n- Tar preparations; low cost, effective (limited by odor, \\nirritation, clothing stains)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 39, 'page_label': '40'}, page_content='Psoriasis\\n\\uf0a4 Systemic\\n- Methotrexate; Folic acid antagonist that inhibits DNA \\nsynthesis & causes immunosuppression (Bone marrow and \\nhepatic toxicity, nausea, anorexia, fatique, oral ulceration)\\n- Cyclosporine; Immunosuppressant that inhibits IL-2 \\nproduction & thus reduces T-cell proliferation (Renal toxicity, \\nhypertension)\\n- Acitretin; Inhibits cell replication by modulating cellular \\ndifferentiation within the epidermis. May combine with PUVA \\nor UVB.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 40, 'page_label': '41'}, page_content='Psoriasis\\n\\uf0a4 Phototherapy\\n- UVB (narrowband ultraviolet B); administer 2-5 times per \\nweek.\\nor\\n- PUVA; Interferes (Psoralen plus ultravioletA) with DNA \\nsynthesis, decreases cellular proliferation, and induces \\napoptosis of cutaneous lymphocytes leading to localized \\nimmunosuppression. Administer 3 times per week until clear, \\nthen tapered. (Skin cancer development, photoaging)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 41, 'page_label': '42'}, page_content='Psoriasis\\n\\uf0a4 Newer Biological Agents\\n- Alefacept ; Fusion protein of Fc receptor of human lgG1 and LFA3. (IM; \\nwhen effective long remissions; monitoring of CD4 q wk; slow onset)\\n- Efalizumab ; Humanized monoclonal antibody to CD11 a; blocks LFA-1/ \\nICAM interaction. (SC; rapidly effective, but rebound; risk of \\nthrombocytopenia)\\n- Etanercept ; Fusion protein directed against soluble TNFa(SC; effective for \\npsoriasis & psoriatic arthritis; rapid onset; no monitoring; use +/- MTX)\\n- Infliximab ; Chimeric monoclonal antibody against TNFa (IV; Fast onset and \\nvery effective; must do PPD; infusion reactions.\\n- Adalimumab ; Fully humanized anti-TNF monoclonal antibody (SC; newest \\nof the biologics, still being studied.\\nNote TNF drugs avoid or use with caution in presence of CHF, demyelination \\ndisorders. Increased risk of opportunistic infections.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 42, 'page_label': '43'}, page_content='Psoriasis\\n\\uf0a4 Scalp; 10% salicylic acid in mineral oil qhs, tar shampoo \\nqd, steroid lotion, calcipotriol lotion.\\n\\uf0a4 Nails; Intradermal triamcinolone acetonide injections \\n(painful), methotrexate, new biologics.\\n\\uf0a4 Generalized psoriasis (>10% BSA) benefits from systemic \\ntherapy, best administered by an experienced physician'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 43, 'page_label': '44'}, page_content='Vitiligo\\n\\uf0a4 Acquired skin disorder characterized by well-defined \\nareas of complete epidermal depigmentation; various \\npathogenesis theories; likely a large autoimmune \\ncomponent\\n\\uf0a4 History; Asymptomatic: 50% present before age 20, 1-2% \\naffected, rare in infancy & old age\\n\\uf0a4 Associated with immune disorder; therefore workup for \\nthyroid disease, diabetes, pernicious anemia and other \\nautoimmune diseases occasionally indicated'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 44, 'page_label': '45'}, page_content='Vitiligo\\n\\uf0a4 Physical: Stark white patch with well-demarcated border; \\nhair in vitiligo patches appears white or gray\\n\\uf0a4 Increased risk of sunburn and skin cancer in amelanotic\\nareas\\n\\uf0a4 Investigations; Wood’s lamp accentuates areas of vitiligo\\n& helps determine extent; consider TSH and fasting blood \\nglucose\\n\\uf0a4 DDx; Leprosy, pityriasis alba, tinea vesicolor, tuberous \\nsclerosis, nevus depigmentosus'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 45, 'page_label': '46'}, page_content='Vitiligo'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 46, 'page_label': '47'}, page_content='Vitiligo\\n\\uf0a4 Management\\n- Mainly for cosmetic, psychological burden\\n- Topical steroids and new topical immunomodulators (tacrolimus & pimecrolimus), \\nPUVA, NB-UVB, phototherapy\\n- Camouflage makeup\\n- Note that facial and more proximal lesions respond better than acral lesions\\n- Surgical transplants can be considered in stable vitiligo\\n- If extensive, can consider bleaching of nonaffected areas to result in total white \\ncolor\\n- -Advise; importance of sun protection'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 47, 'page_label': '48'}, page_content='Molluscum Contagiosum\\n\\uf0a4 Etiology: Self-limited viral infection of skin caused by \\npoxvirus affecting mainly children.\\n\\uf0a4 Immunocompromised patients (e.g., HIV) may develop \\nmore widespread and larger lesions\\n\\uf0a4 History: Asymptomatic; occasional perilesional pruritus, \\nvery common in children. Spread by direct contact or \\nautoinoculation. Lesions tend to be more numerous and \\nspread rapidly in patients with atopic dermatits.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 48, 'page_label': '49'}, page_content='Molluscum Contagiosum\\n\\uf0a4 Physical: 2- to 6- mm firm, flesh colored, dome-shaped, \\numbilicated pearly papules; most common affected sites –\\ntrunk and face of children, genital/inner thigh of sexually \\nactive adults\\n\\uf0a4 Molluscum papules in a child in the periorbital region. \\nLesions can be spread by picking and scratching. Lesions \\nwill be resolve with development of cellular immunity. \\n\\uf0a4 Course: lesions typically involute spontaneously within 9-12 \\nmo; may develop adjacent eczema (10%)\\n\\uf0a4 Investigation: clinical diagnosis, biopsy if uncertain\\n\\uf0a4 DDx: BCC, milia, other infection, warts'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 49, 'page_label': '50'}, page_content='Molluscum Contagiosum\\n\\uf0a4 Management\\n- Observation\\n- Liquid Nitrogen Cryotherapy\\n- Curettage: may be uncomfortable\\n- Papule incision with a scalpel blades or at home sharp fingernail and expression of \\ncontents\\n- Topical cantharidin 0.7%: Blistering will occur\\n- Imiquimod cream, Tretinoin cream\\n- In children with widespread involvement, may consider oral cimetidine (40 \\nmg/kg/d ) for 2 mo.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 50, 'page_label': '51'}, page_content='Molluscum Contagiosum'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 51, 'page_label': '52'}, page_content='Pityriasis Versicolor (Tinea Versicolor)\\n\\uf0a4 Etiology : Common superficial cutaneous fungal infection \\ncaused by Malassezia furfur (Pityrosporum orbiculare), The \\norganism is part of normal skin\\n\\uf0a4 History : May itch but usually asymptomatic, young adults \\ntypically affected (years of higher sebaceous activity) ; \\ncommonly recurs (40-60%) ; more common in hot and humid \\nenvironments.\\n\\uf0a4 Cushing disease, pregnancy, mulnutrition, corticosteroid \\ntherapy, immunosuppression, oral contraceptives may lower \\nresistance, allowing this normally non-pathogenic resident \\nyeast to poliferate'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 52, 'page_label': '53'}, page_content='Pityriasis Versicolor (Tinea Versicolor)\\n\\uf0a4 Physical : Round to oval macules and patches on the \\ntrunk extending to the upper arms, neck, abdomen; \\ndifferent colors: White, orange-brown, dark-brown; very \\nfine scale; postinflammatory hypopigmentation is often \\nnoted rather than initial erythema.\\n\\uf0a4 Investigations: KOH test reveals diagnostic “spaghetti & \\nmeatballs” (hyphae & spores); Wood’s lamp shows \\nyellow-brown fluorescence. Skin biopsy if diagnosis \\nuncertain.\\n\\uf0a4 DDx : Tinea corporis, vitiligo, psoriasis.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 53, 'page_label': '54'}, page_content='Pityriasis Versicolor (Tianea Versicolor)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 54, 'page_label': '55'}, page_content='Pityriasis Versicolor (Tianea Versicolor)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 55, 'page_label': '56'}, page_content='Pityriasis Versicolor (Tianea Versicolor)\\n\\uf0a4 Management\\n\\uf0a4 Topical or systemic treatment.\\n\\uf0a4 Nizoral shampoo (ketoconazole 2%) applied onto dampened \\ntrunk skin, lathered for 5 min before rinsing, x 3 d.\\n\\uf0a4 Topical selenium sulfide 2.5% shampoo applied for 15 min x 3 d.\\n\\uf0a4 Topical nizoral cream 2% (ketoconazole) bid x 2 wk.\\n\\uf0a4 Systemic ketoconazole 200 mg po qd x 5 – 7 d or fluconazole \\n400 mg x 1. Postinflammatory hypopigmentation may persist for \\n6 – 12 mo.\\n\\uf0a4 Even with treatment, tendency to recur in summer.\\n\\uf0a4 Zinc pyrithione soap lather may be applied to the body 1 – 3 \\ntimes weekly for prevention.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 56, 'page_label': '57'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4 Dermatophyte digest and invade keratin then infect skin, \\nnails and hair; incubation period = 1-3 weeks\\n\\uf0a4 Trychophyton, Microsporum, Epidermophyton species \\ncommonly involved.\\n\\uf0a4 Risk Factors; Hot, humid environment, sweating or \\nmaceration of the skin, occlusive footwear, Diabetes \\nmellitus, immunosuppression\\n\\uf0a4 History: Asymptomatic; occasionally mild pruritus'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 57, 'page_label': '58'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4 Physical; Scalp hair and general body surfaces mostly \\naffected during childhood; hand, foot or nail infections \\nare more common after puberty\\n\\uf0a4 Immunologic response to a dermatophyte infection may \\nresult in a dermatophytid reaction: Vesicular eruption on \\nacral surfaces, especially the palms'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 58, 'page_label': '59'}, page_content='Tinea (Dermatophyte) Infection'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 59, 'page_label': '60'}, page_content='Tinea (Dermatophyte) Infection'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 60, 'page_label': '61'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4 Investigations; Skin scraping analysis with KOH prep –\\nSeptate hyphae branching at various angles are seen; \\nfungal culture\\n\\uf0a4 DDx; Eczema, granuloma annulare, psoriasis'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 61, 'page_label': '62'}, page_content='Tinea Capitis\\n\\uf0a4 Caused by invasion of stratum corneum and hair shaft with fungal \\nhyphae.\\n\\uf0a4 Four clinical infection patterns;\\n- Seborrheic dermatitis type- Diffuse, patchy scale on scalp\\n- Black dot pattern- hyphae invade hair shaft. Hair then broke at \\nscalp surface. Broken shaft like black dots. Round area of alopecia \\nwithout inflammation\\n- Inflammation tinea capitis (kerion)- Deep boggy round masses with \\npustules, surface exudate\\n- Pustular- Pustules areas without scaling, significant hair loss may be \\npresent, look like scalp bacterial infection.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 62, 'page_label': '63'}, page_content='Seborrheic dermatitis type – Tinea\\nCapitis'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 63, 'page_label': '64'}, page_content='Black dot pattern – Tinea Capitis'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 64, 'page_label': '65'}, page_content='Inflammation tinea capitis (kerion) –\\nTinea Capitis'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 65, 'page_label': '66'}, page_content='Tinea Capitis\\n\\uf0a4 Management\\n- Examine sibling and household members, clean or discard \\ncontaminated objects.\\n- Griseofulvin; usually 6-12 weeks\\n- Itraconazole and fluconazole; taken for 4-8 weeks. A single dose of \\n150 mg once weekly for 4 weeks also be effective for older children\\n- Shampoo with selenium sulfide 1% or ketoconazole every other day \\nfor the first 2 weeks, then twice weekly throughout course of rest of \\noral therapy. Shampoo is left for 5 min\\n- Consider suppression kerion inflammation with prednisolone 1-2 \\nmg/kg qd or intralesional triamcinolone 10 mg/cc'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 66, 'page_label': '67'}, page_content='Erythema Nodosum\\n\\uf0a4 Common form of septal panniculitis that is usually a reactive skin response to \\nan associated trigger\\n- Infections; Bacterial (e.g., streptococcal pharyngitis), microbacterial\\n(tuberculosis)\\n- Drugs; e.g., oral contraceptives, sulfonamides\\n- Sarcoidosis\\n- Inflammatory bowel disease\\n- Behcet disease\\n- Malignancy\\n- - Pregnency'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 67, 'page_label': '68'}, page_content='Erythema Nodosum\\n\\uf0a4 History; Lesions may be associated with fever, malaise, \\nleg edema and arthralgia. Resolution after 2-6 wk\\n\\uf0a4 Physical; painful, dull, erythematous nodules 1-5 cm in \\ndiameter, located on anterior lower legs of young \\nwoman. No ulceration, discharge or scarring\\n\\uf0a4 Investigation; Through review of systems: CBC, UA, chest \\nx-ray and throat swab\\n\\uf0a4 DDx; Insect bite reaction, erysipelas, urticaria'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 68, 'page_label': '69'}, page_content='Erythema Nodosum'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 69, 'page_label': '70'}, page_content='Erythema Nodosum\\n\\uf0a4 Management\\n- Investigate for and treat underlying cause.\\n- Most patients benefit from bed rest, applying ice or cool \\ncompresses, elevating legs & NSAIDs\\n- Less common Tx choice; Oral prednisolone, colchicine, \\ndapsone'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 70, 'page_label': '71'}, page_content='Necrobiosis lipodica\\n\\uf0a4 An inflammatory condition of degenerative collagen. \\nWhen present, it is often associated with diabetes\\n\\uf0a4 Lesions usually develop slowly and are often \\nasymptomatic, onset may occur at any age but the \\ndisease most common starts at 3rd – 4th decade. About \\n75% of those affected are women'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 71, 'page_label': '72'}, page_content='Necrobiosis lipodica\\n\\uf0a4 Physical Findings\\n\\uf0a4 Lesion are usually limited to the anterior shins but may be seen \\non calve and thighs, and rarely on the arms, hands, feet and \\nscalp.\\n\\uf0a4 They begin as round, violaceous patches and slowly expand. \\nThe advancing border is red, and the central area turns a \\ncharacteristic orange-yellow brown. The central area atrophies \\nand shows a shiny, waxy surface with prominent telangiectasias.\\n\\uf0a4 Ulceration may occur, particulary after trauma, in about 15% of \\ncases. These ulcers are exquisitely tender.\\n\\uf0a4 The number or severity of lesions or ulcerations has not been \\ncorrelated with the degree of diabetic control.\\n\\uf0a4 The course is unpredictable. Lesions usually heal with atrophic \\nscarring, or can be chronic and recurrent.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 72, 'page_label': '73'}, page_content='Necrobiosis lipodica\\n\\uf0a4 Treatment\\n\\uf0a4 Topical and intralesional steroids slow the inflammation but may \\npromote further atrophy. Middle- to high-potency \\ncorticosteroids can be used under occlusion.\\n\\uf0a4 Intralesional injections of triamcinolone acetonide 10 mg/mL \\ncanbe helpful.\\n\\uf0a4 A short course (5-6 weeks) of oral corticosteroids can be \\nconsidered if disease activity and symptoms are severse, but this \\nis rarely the case.\\n\\uf0a4 Pentoxifylline (Trental) 400mg t.i.d. has been advocated by \\nsome and has been used in combination with low-dose aspirin \\nfor ulcerating necrobiosis lipoidica. \\n\\uf0a4 Skin grafting can be performed for extensive disease.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 73, 'page_label': '74'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d Common idiopathic benign epidermal growth\\n\\uf07d Common in fourth decade\\n\\uf07d Males and females equally affected\\n\\uf07d More common in fair skin\\n\\uf07d Possibly autosomal dominant\\n\\uf07d Gradual development; occasionally pruritic or sore'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 74, 'page_label': '75'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d Well circumscribed  epidermal growth, raised lesions\\n\\uf07d Waxy round-oval papules and plaques with verrucous or \\ncrusted surface. Sharp border\\n\\uf07d “Stuck on” appearance \\n\\uf07d Starts as light brown macule \\n larger and verrucous with \\ntime\\n\\uf07d Also, smooth-surfaced lesions contain dark or light round \\nhorn pearls embedded in the lesion or protruding from the \\nsurface. \\n\\uf07d Variably pigmented and size\\n\\uf07d Most commonly: trunk, neck, arms, scalp; wide range of size'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 75, 'page_label': '76'}, page_content='Seborrheic Keratosis - SK\\n\\uf0a4 Leser-Trelat sign: Sudden, eruptive seborrheic keratoses in \\nelderly individuals, often with inflammatory base may be \\na sign of an associated internal (stomach cancer & \\nothers) malignancy as part of paraneoplastic syndrome'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 76, 'page_label': '77'}, page_content='Seborrheic Keratosis - SK\\n\\uf0a4 Investigation: Clinical diagnosis; skin biopsy if uncertain.\\n\\uf0a4 DDx: AK, BCC, lentigo, melanoma, nevus, skin tag, wart'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 77, 'page_label': '78'}, page_content='Seborrheic Keratosis - SK'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 78, 'page_label': '79'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d Treatment may be indicated for symptomatic lesions which \\nare inflamed, irritated or bleeding.\\n\\uf07d THERAPIES\\n◦ Cryotherapy; for flat to minimally raised lesions. \\n◦ Light cautery/electrodessication \\n◦ Shave excision\\n◦ Laser\\n\\uf096 Not effective for thicker lesions \\n\\uf096 Ruby (694nm)\\n\\uf096 Alexandrite (755nm)\\n\\uf096 CO2\\n\\uf096 Erbium'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 79, 'page_label': '80'}, page_content='Actinic Keratosis - AK\\n\\uf07d Most common precancerous lesions in humans, and more \\nprevalent in fair-skinned individuals who tan poorly and burn \\neasily.\\n\\uf07d Found in sun-exposed skin \\n◦ Face, ears\\n◦ Neck, forearms\\n◦ Dorsal hands\\n\\uf07d Outdoor occupations, ionizing radiation, \\nand arsenic exposure'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 80, 'page_label': '81'}, page_content='Actinic Keratosis - AK\\n\\uf07d Common in skin type I-III\\n\\uf07d Secondary to cumulative keratinocyte damage\\n\\uf07d Atypical keratinocytes confined to epidermal basal layer\\n\\uf07d < 1% progress to skin cancer (squamous cell carcinoma, SCC)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 81, 'page_label': '82'}, page_content='Actinic Keratosis - AK\\n\\uf0a4 Clinical appearance\\n- Slightly erythematous, rough, scaly papules on sun-exposed \\nareas\\n- May be difficult to see, but often feel rough: Palpation is \\nessential to diagnosis.\\n- Most commonly in the elderly\\n- DDx: BCC, Bowen disease, SCC\\n- Investigation: Biopsy if recurrent, unresponsive to treatment, \\nor pronounced hyperkeratosis and induration'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 82, 'page_label': '83'}, page_content='Actinic Keratosis - AK\\n\\uf07d Treatment options\\n◦ Topical\\n\\uf096 5%  5-flourouracil  (Carac, Efudex) applied bid for 2-4 \\nwk\\n\\uf096 5% Imiquimod (Aldara) applied three to five times \\nweekly for 12 wk\\n\\uf096 Expect \\n erythema, irritated, inflamed and crusting; \\nfollow-up visit in 1-2 wk to evaluate severity of side \\neffects'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 83, 'page_label': '84'}, page_content='Actinic Keratosis - AK\\n◦ Liquid Nitrogen Cryotherapy for limited lesions\\n◦ Electrodesication and curettage, CO2 laser\\n◦ Dermabrasion\\n◦ Chemical peel (for numerous AKs)  \\n\\uf096 Serial medium depth \\n TCA\\n◦ Light Therapy\\n\\uf096 PDT with ALA. Pulsed CO2\\nSun-awareness and protection advice'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 84, 'page_label': '85'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Most common cutaneous malignancy derived from stem \\ncells of epidermis. Locally invasive, slow-growing, rarely \\nmetastasizes (unless patients is immunocompromised)\\n\\uf0a4 Etiology: Chronic UV exposure (Cumulative sun exposure \\nis primary risk factor), radiation, immunosuppression, \\ngenetics (e.g., nevoid basal cell carcinoma syndrome)\\n\\uf0a4 History: Persistent, nonhealing papule or nodule that \\nulcerates or bleeds (beefy-red smooth erosive nodule). \\nCommon in elderly (most common after 40) Caucasians.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 85, 'page_label': '86'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Physical: Pearly papule or nodule with telangiectases, \\nrolled border; central crust or ulceration.\\n\\uf0a4 Distributed mostly on sun-exposed areas, i.e., head and \\nneck (85%). Variants: Superficial, nodular, sclerosing\\n(morpheaform), pigmented\\n\\uf0a4 DDx: Melanoma, nevus, SCC\\n\\uf0a4 Investigations: Biopsy must be performed to confirm \\ndiagnosis and classify subtype.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 86, 'page_label': '87'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Physical Findings\\n- Nodular BCC: Most common variant. A pearly white, \\nalmost translucent, dome-shaped papule with overlying \\ntelangiectasias. Papule or nodule enlarges slowly, may \\nbecome flattened in center or may develop a raised, rolled, \\ntranslucent border. Frequently ulcerates, bleeds, becomes \\ncrusted in center'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 87, 'page_label': '88'}, page_content='Basal Cell Carcinoma - BCC\\n- Pigmented BCC: contains melanin, may therefore \\nresemble melanoma\\n- Superficial BCC: least aggressive form. More commonly \\non trunk, extremities. Circumscribed, round to oval, red, \\nscaling plaque resembles eczema, psoriasis, \\nextramammary Paget disease or Bowen disease\\n- Sclerosing BCC : Most subtle and least common variant. \\nSmooth, pale white to yellow papules. Resembles scar \\ntissue. Borders may be difficult to discern. Higher rate of \\nrecurrence'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 88, 'page_label': '89'}, page_content='Basal Cell Carcinoma - BCC\\nNodular BCC'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 89, 'page_label': '90'}, page_content='Basal Cell Carcinoma - BCC\\nPigmented BCC'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 90, 'page_label': '91'}, page_content='Basal Cell Carcinoma - BCC\\nSuperficial BCC'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 91, 'page_label': '92'}, page_content='Basal Cell Carcinoma - BCC\\nSclerosing BCC'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 92, 'page_label': '93'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Management\\n- Advise that metastases and death are extremely rare. Vast \\nmajority cause no major problem, but should be treated\\n- Without treatment, BCCs persist, enlarge, ulcerate, invade, \\ndestroy surrounding structures \\n- Tx options depend on histological subtype and location: \\nLiquid nitrogen cryotherapy (requires experience), \\ncurettage & electrodessication (most common Tx), excision, \\nMohs micrographic surgery, imiquimod cream for superficial \\nsubtype, 5-FU, CO2 laser, radiation therapy\\n- Advise on sun protection'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 93, 'page_label': '94'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Electrosurgery of obvious tumor. The 5 year cure rate \\napproach 92%\\n\\uf0a4 Primary excision is preferred for non-facial, well-defined \\nnodular. The 5 year rate approach 90%\\n\\uf0a4 Mohs microsurgery is a highly specialized, tissue-sparing \\nmethod of excision used for difficult tumors with \\ncontiguous growth. It is also used for recurrent BCC, \\nhistological  aggressive forms of BCC, such as sclerotic \\nBCCs, and tumors in anatomically important locations \\nsuch as around eyes, nasal alar, mouth and ears.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 94, 'page_label': '95'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Radiation therapy may be useful for difficult-to-treat \\ntumors, such as eyelids, and for patients unable to \\ntolerate surgery. The 5 year cure rates are roughly 90%\\n\\uf0a4 Photodynamic therapy is an evolving chemotherapeutic \\nmodality for superficial BCC\\n\\uf0a4 Topical imiquimod 5% cream is an immune response \\nmodifier shown to be about 85% effective or better for \\nsuperficial BCC. It is less effective for nodular BCC'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 95, 'page_label': '96'}, page_content='Squamous Cell Carcinoma (SCC)\\n2nd most common form of skin cancer (after BCC) arising in sun \\nexposed areas in elderly; due to malignant keratinocytes with \\nmetastatic potential.\\n\\uf0a4 Etiology : Chronic UV-damage is the primary cause, \\nimmunosuppression, burns leg ulcers, chemical carcinogens \\n(e.g., tar), HPV; can occur in discoid lupus, lichen sclerosus, \\n& any scarring processes.\\n\\uf0a4 History : Slow-growing, nonhealing scaly papule on sun-\\nexposed area of head, neck, dorsal hands, and forearms; \\nalso affects mucous membranes (lower lip: M >> F, smokers, \\n10% - 15% metastatic rare); rare in dark skin.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 96, 'page_label': '97'}, page_content='Squamous Cell Carcinoma (SCC)\\n\\uf0a4 Physical : Firm indurated papule, plaque, or nodule with \\nadherent rough scale on sun-exposed areas. Normally with \\nnecrotic crusted center. Removal of crust reveals central \\ncavity filled with necrotic keratin debris.\\n\\uf0a4 Actinic keratosis is considered a precursor lesion; actinic \\ncheilitis is the precursor on lip.\\n\\uf0a4 Ultimately, tumors metastasize, via the lymphatics to other \\norgans\\n\\uf0a4 Investigations : Biopsy (to mid-dermis) for confirmation.\\n\\uf0a4 DDx : AK, BCC, SK, amelanotic melanoma, wart.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 97, 'page_label': '98'}, page_content='Squamous Cell Carcinoma (SCC)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 98, 'page_label': '99'}, page_content='Squamous Cell Carcinoma (SCC)\\n\\uf0a4 Management\\n\\uf0a4 Wide local excision with histologic confirmation of margins.\\n\\uf0a4 Lymp node biopsy indicated for suspected nodal disease\\n\\uf0a4 Liquid nitrogen cryotherapy\\n\\uf0a4 Mohs micrographic surgery\\n\\uf0a4 Less commonly topical imiquimod or radiation\\n\\uf0a4 Advide on sun protection.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 99, 'page_label': '100'}, page_content='Melanoma\\n\\uf0a4 Etiology : Melanocyte-derived skin cancer. May arise within \\na previously existing nevus or dysplastic nevus, but ~ 70% \\narise de novo \\n\\uf0a4 History : Risk factors\\n\\uf0a4 Fair complexion: Red/blonde hair, blue/green eyes, tendency to \\nfreckle and burn.\\n\\uf0a4 Sun exposure, particularly blistering sunburns during childhood.\\n\\uf0a4 Personal of family history of melanoma; Genes involved in some \\ncases: CDKN2A, BRAF.\\n\\uf0a4 Giant congenital melanocytic nevi or multiple dysplastic nevi.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 100, 'page_label': '101'}, page_content='Melanoma\\n\\uf0a4 Physical: Pigmented macule or plaque with some or all of the \\nfollowing features \\nABCDE of melanoma: \\n- Asymmetry\\n- Borders (irregular)\\n- Color variegation\\n- Diameter (> 6mm)\\n- Evolution (lesion change by history)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 101, 'page_label': '102'}, page_content='Melanoma\\nClassically divided into subtypes based on clinical and histopathologic features:\\n1. Superficial spreading malignant melanoma – 60%-70% of melanomas.\\n2. Nodular melanoma.\\n3. Acral-lentiginous melanoma – Most common form in blacks, Asians, and \\nHispanics, mostly on volar skin of the palms or soles and the nailbeds.\\n4. Lentigo maligna melanoma – Develops from a lentigo maligna, usually on the \\nface of elderly, slow-growing.\\n5. Amelanotic melanoma – Pink-red.\\n6. Rare variants.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 102, 'page_label': '103'}, page_content='Superficial spreading malignant \\nmelanoma'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 103, 'page_label': '104'}, page_content='Nodular melanoma'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 104, 'page_label': '105'}, page_content='Acral-lentiginous melanoma'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 105, 'page_label': '106'}, page_content='Lentigo maligna melanoma'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 106, 'page_label': '107'}, page_content='Amelanotic melanoma'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 107, 'page_label': '108'}, page_content='Melanoma\\n\\uf0a4 Most common sites of local and/or regional metastases-\\nDraining lymph node basins and the skin between the \\nprimary site and the lymph nodes.\\n- Most common sites of systemic metastases – Lung, Liver, \\nbrain (#1 cause of death), bone, and gastrointestinal tract. \\n\\uf0a4 Investigations: Dermoscopy (ABCD rule), excisional biopsy if \\nmelanomais suspected\\n\\uf0a4 Most important prognostic indicator is maximal thickness of \\ntumor invasion on biopsy (Breslow depth in mm)\\n\\uf0a4 DDx: BCC, blue or dysplastic nevus, SK'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 108, 'page_label': '109'}, page_content='Melanoma\\n\\uf0a4 Management\\n- Wide surgical excision; based on Breslow depth: 5 mm for \\nmelanoma in situ, 1 cm for melanoma <1mm, 2 cm for \\nmelanoma >1mm\\n- Sentinel lymph node biopsy depending on clinical\\n- Adjuvant high-dose interferon & IL-2 may provide benefit for \\nmetastatic disease\\n- Perfusion chemotherapy for extremity melanoma\\n- Radiation'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 109, 'page_label': '110'}, page_content='Atopic Dermatitis\\n\\uf0a4 Chronic inflammatory dermatosis affecting 10%-20% of \\nchildren (esp. infants and young children)\\n\\uf0a4 Etiology: Cutaneous immune dysfunction; IgE-mediated; \\ngenetics. Strong associated with personal and family \\nhistory of atopy (eczema, asthma)\\n\\uf0a4 History: “Pruritus” is a hallmark (“the itch that rashes”). \\nAggravating factors: sweating, contact sensitivity, \\nsecondary infection, wool, food allergy, stress/anxiety.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 110, 'page_label': '111'}, page_content='Atopic Dermatitis\\n\\uf0a4 Acute: Erythematous, excoriated, scaling patches and plaques; \\nmore lichenification in chronic forms.\\n\\uf0a4 Distribution:\\n- Infants: Cheeks, forehead, scalp, extensor surfaces of extremities\\n- Child: Flexural surfaces- antecubital and popliteal fossae, wrists, \\nankles\\n- Adults: Hands, flexural. The prominent finding is lichenification; this \\nindicates a long – standing problem.\\n\\uf0a4 Lesions can be secondarily infected with staphylococcal \\norganisms: impetigo'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 111, 'page_label': '112'}, page_content='Atopic Dermatitis\\nInfants: Cheeks, forehead, scalp, extensor surfaces of extremities'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 112, 'page_label': '113'}, page_content='Atopic Dermatitis\\nChild: Flexural surfaces- antecubital and popliteal fossae, wrists, ankles'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 113, 'page_label': '114'}, page_content='Atopic Dermatitis\\nAdults: Hands, flexural. The prominent finding is lichenification\\n; this indicates a long – standing problem'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 114, 'page_label': '115'}, page_content='Atopic Dermatitis\\n\\uf0a4 DDx: Contact dermatitis, psoriasis, seborrheic dermatitis\\n\\uf0a4 Investigation: Allergy or RAST testing of little value (Patch \\ntest if dermatitis pattern changes or refractory to \\ntreatment. \\n\\uf0a4 Diagnosis Requires: History of an itchy skin condition (or \\nparental report of scratching/rubbing by the child)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 115, 'page_label': '116'}, page_content='Atopic Dermatitis\\n\\uf0a4 Plus ≥3 of :\\n1. History of involvement of skin crease (antecubital, popliteal, anterior \\nankles or around the neck) or cheeks in children < 10 years\\n2. Personal history of asthma or hay fever (or history of atopic disease \\nin 1st degree relative if < 4 years of age)\\n3. History of generalized dry skin in the past year.\\n4. Visible flexural dermatitis (or eczema on the cheeks/forehead and \\nouter limbs in children < age 4 years)\\n5. Onset under the age of 2 (do not use as criterion if patient is < age 4 \\nyears)'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 116, 'page_label': '117'}, page_content='Atopic Dermatitis\\n\\uf0a4 Minor, less specific feature: \\n- xerosis, ichthyosis, palmar hyperlinearity, keratosis pilaris. \\nImmediate type 1 skin test responses, dermatitis of hands \\nand feet, cheilitis, nipple eczema, increased susceptibility to \\ncutaneous infection, perifollicular accentuation'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 117, 'page_label': '118'}, page_content='Atopic Dermatitis\\n\\uf0a4 Management\\n- Elimination of precipitating irritants: avoid wool and synthetic \\nfabrics; wear cotton clothes, humidifier at home; dietary \\nrestriction if specific verified food allergy; stress reduction.\\n- Skin hydration: Baths with emollients, apply thick \\nnonfragranced emollient immediately after bath.\\n- Topical steroids: 1% hydrocortisone ointment bid to face \\nand folds, midpotency steroids bid to other effected areas; \\nointments more occlusive and more effective than creams.'),\n",
       " Document(metadata={'producer': 'Microsoft® PowerPoint® 2016', 'creator': 'Microsoft® PowerPoint® 2016', 'creationdate': '2019-05-29T13:06:19+07:00', 'title': 'Common Skin Disease', 'author': 'Surangkana Veeranawin', 'moddate': '2019-05-29T13:06:19+07:00', 'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf', 'total_pages': 119, 'page': 118, 'page_label': '119'}, page_content='\\uf0a4 Management\\n- Steroid-sparing topical immunomodulators can be used bid in \\nchildren > 2 yr: Pimecrolimus cream – mild to moderate eczema. \\nTacrolimus – moderate to severe eczema.\\n- Oral antihistamines with sedative effect may offer symptomatic \\nrelief of the associated pruritus, e.g., hydroxyzine (3-5 mg/kg/d divided \\ntid/qid)\\n- If secondarily infected: antibiotic therapy\\n- If patients refractory to conventional therapy, other systemic Tx\\nchoices include: PUVA or UVB light therapy, systemic steroids (short \\ncourses), methotrexate, cyclosporine: usually administered by \\ndermatologist')]"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pdf_path=\"data/3-Lecture-Common-Skin-Disease-2019.pdf\"  # Removed leading slash for Windows compatibility\n",
    "def load_and_split_data(pdf_path):\n",
    "    loader = PyPDFLoader(pdf_path)\n",
    "    documents = loader.load()  # Fixed method name to lowercase\n",
    "    text_splitter = RecursiveCharacterTextSplitter(chunk_size=1000, chunk_overlap=200)\n",
    "    texts = text_splitter.split_documents(documents)  # Split the documents\n",
    "    return texts  # Return the split texts\n",
    "\n",
    "extracted_data=load_and_split_data(pdf_path)\n",
    "extracted_data # Display the first chunk of extracted data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "de855fa3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "119\n"
     ]
    }
   ],
   "source": [
    "print(len(extracted_data))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "266c3dc4",
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import List \n",
    "from langchain.schema import    Document\n",
    "\n",
    "def filter_to_minimal_chunk(extrac)->List[Document]:\n",
    "    minimal_docs:List[Document]=[]\n",
    "    for doc in extracted_data:\n",
    "        minimal_docs.append(\n",
    "            Document(\n",
    "                page_content=doc.page_content,\n",
    "                metadata={\"source\":doc.metadata.get(\"source\")}\n",
    "                )\n",
    "            \n",
    "            )\n",
    "    return minimal_docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "9cb66c29",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "typing._GenericAlias"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "type(List[Document])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "c3071b25",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Common Skin Disease\\nSurangkana Veeranawin, MD\\nMSc, Queen Mary University of London\\nMmed, University of Sydney\\nDipDerm RCPS(Glas.)\\nDiplomate American Broad of Aesthetic Medicine (ABAM)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne Vulgaris\\n\\uf0a4 Inflammatory disorder of pilosebaceous follicle with a 90% \\nprevalence in adolescence and young adulthood.\\n\\uf0a4 History: often asymptomatic lesions (especially comedone), \\nalthough can be tender (nodules)\\n\\uf0a4 Physical: two types of lesions, predominantly affect face, \\nneck, chest and back\\n- Noninflammatory; open(“black head”) and closed (“white \\nhead”) comedones\\n- Inflammatory; papules, pustule, cysts, nodule: deep lesions \\n(leave scars)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne Vulgaris\\n\\uf0a4 4 Major components\\n• Abnormal follicular keratinization: follicular wall cells fail to \\ndesquamate to the surface in the normal manner.\\n• Sebum over production secondary to androgen\\n• Propionibacterium acnes infection; they grow in the \\nsebum-cell mixture.\\n\\uf0a7 Inflammation\\n\\uf0a4 Other components; genetic factors, occlusive cosmetic \\nagents, medication (steroids, ACTH, androgens, lithium, \\nantiepileptics, oral contraceptives), diseases (PCOS, \\nCongenital Adrenal Hyperplasia)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nTreatment Strategies\\n- Retinoid for clearing pores and comedones for all acne \\nconditions\\n- Small inflammatory lesions \\uf0e0Topical Benzoyl Peroxide (BP) &  \\nTopical Antibiotic\\n- Large inflammatory lesions \\uf0e0 Oral antibiotic'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nMild \\uf0e8\\uf0e8 Topical Only\\n\\uf0a4 Decrease follicular plugging\\n• Retinoid \\n• Nightly\\n• Adapalene (Differin); if can not tolerate retinoid\\n• Salycilic acid wash/scrub\\n\\uf0a4 Decrease P. Acne\\n• Topical Antibiotic \\n• Clindamycin  \\n• Benzoyl peroxide; bacterialcidal, decrease sebum/oil'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nModerate or nonresponsive to topical\\n\\uf0a4 Add oral antibiotic\\n• Tetracycline\\n250 – 500 mg twice/day\\n• Minocycline \\n50 – 100 mg twice/day\\n• Doxycycline\\n50 – 100 mg twice/day\\n\\uf0a4 Add chemical peel  \\uf0e0 Salicylic or Jessner'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\n\\uf0a4 Other treatment\\n- comedone extraction, intralesional cortisone injection (for \\npapulonodules, cysts), oral contraceptives (esp. anti-\\nandrogenic such as cyproterone acetate), photodynamic \\ntherapy, spironolactone (reduces androgen production; 50 \\n– 200 mg/day), dermabrasion\\n- Patients should be forewarned of acne exacerbations in \\nthe first month of systemic therapy as deep-seated acne \\ncomes to the surface. Also, systemic therapy can required 6 \\nwk before benefits are noted'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4 Chronic vascular & acneiform disorder\\n\\uf0a4 Common chronic inflammatory disorder of pilosebaceous units \\nand vasculature of the face\\n\\uf0a4 Role of Demodex mite controversial\\n\\uf0a4 Increase reactivity of capillaries \\uf0e8\\uf0e8\\uf0e8Flushing\\uf0e8\\uf0e8\\uf0e8ultimately \\nleading to telangiectasia'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4 Easy and recurrent flushing\\n\\uf0a4 Sensitive skin\\n\\uf0a4 More common in fair skin\\n\\uf0a4 May complain of dry and gritty eyes\\n\\uf0a4 Female > male\\n\\uf0a4 Peak incidence 30-50 yr'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\nEXACEBATE BY\\n\\uf0a4 Heat,rapid change in temperature\\n\\uf0a4 Sun exposure\\n\\uf0a4 Cold\\n\\uf0a4 EtOh\\n\\uf0a4 Stress\\n\\uf0a4 Spicy food\\n\\uf0a4 Hot food/beverage\\n\\uf0a4 Caffeine'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4 Clinical appearance: Erythema, telangiectases, papules, \\nand pustules of central face; no comedones in contrast \\nto acne.\\n\\uf0a4 Erythema of the nose is highly characteristic of rosacea\\n\\uf0a4 Accompany with, sebaceous hyperplasia, seborrheic\\ndermatits & facial lymphedema more common'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4 Predominantly central face\\n- Forehead\\n- Cheeks\\n- Nose\\n- Chin\\n- Occasionally eyelids'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4 4 Major subtypes\\n\\uf0a4 Vascular rosacea ( Erythematotelangiectatic rosacea)\\n\\uf0a4 Papulopustular rosacea\\n\\uf0a4 Ocular rosacea: gritty, conjunctival injection, styes and \\nphotophobia. (The eye is involved in about 50% of cases)\\n\\uf0a4 Nasal sebaceous hyperplasia (rhinophyma): chronic \\ninflammation may progress to rhinophyma (more common in \\nmale)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='ROSACEA'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='ROSACEA\\nRHINOPHYMA\\nPAPULOPUSTULAR'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4 Investigation\\n- Clinical diagnosis\\n- Skin biopsy to rule out lupus or sacoidosis\\n\\uf0a4 Differential Diagnosis\\n- Acne              - Lupus erythematosus - Sarcoidosis\\n- Seborrheic dermatitis     - Perioral dermatitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf07d Management\\n- Based on severity and  subtype.\\n- Lifestyle modification : Avoid triggers ; sun protection & \\navoidance.\\n- Topical antibiotic \\n\\uf096 Metronidazole 0.75% gel or 1% cream bid\\n\\uf096 Sodium sulfacetamide lotion 10% bid\\n\\uf096 Azelaic acid QD'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n- Oral antibiotic (moderate to severe cases with \\ninflammatory papulopaustular component)\\n\\uf096 Tetracycline 500 mg po BID\\n\\uf096 Minocycline 100 mg OD – BID\\n\\uf096 Doxycyline 20 mg po bid (subantimicrobial dose \\ntherapy) or 100 mg po qd-bid\\n- Isotretinoin and prednisolone for very severe cases'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n- Light therapy\\n\\uf096 Treatment of Choice \\uf0e0 IPL (400nm – 1200nm), PDL  \\n(595 nm) for telangiectases\\n\\uf096 Ablative laser (CO2) for rhinophyma\\n- Ophthalmologist to assess for ocular involvement \\n(blepharitis, conjunctivitis)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4 Acute, self-limited papulosquamous inflammatory skin \\nexanthem in 15-40 yr.\\n\\uf0a4 The primary lesion is an oval, salmon-colored, 1-10 cm \\nplaque that forms a round collarette of scale in the \\ncenter.\\n\\uf0a4 It evolves rapidly, usually beginning with patch that \\nheralds the eruption, the so-called “herald patch.\\n\\uf0a4 Clinical appearance: Scaly pink-erythematous plaques; \\npredominantly trunk affected, in “Christmas-tree” pattern'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4 Etiology: Possibly triggered by human herpes virus 7\\n\\uf0a4 History: May be pruritic or asymptomatic; preceding URTI or \\nmild constitutional symptoms\\n\\uf0a4 Lesions are found on the trunk and usually spare the face \\nand extremities\\n\\uf0a4 The number of lesions is highly variable. Plaques may extend \\nto the neck and proximal limbs\\n\\uf0a4 Numerous lesions may appear. A concentration of lesions on \\nthe groin and lower abdomen is highly characteristic, \\nespecially in children'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4 Course: Self-resolving in 6-8 weeks\\n\\uf0a4 Investigations: Clinical; scraping for KOH (R/O tinea) or \\norder RPR (R/O syphilis), or skin biopsy if uncertain.\\n\\uf0a4 DDx: Eczema, psoriasis, tinea corporis, syphilis, seborrheic\\ndermatitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4 Management\\n- Reassurance is key\\n- Symptomatic management of pruritus (e.g. mild topical \\nsteroids, antihistamines); mentholated lotion or sprays for \\nitching\\n- Erythromycin 250 mg, q.i.d or 25-40 mg/kg in four divided \\ndoses in children for 2 weeks may clear the eruption\\n- Light therapy (e.g. UVB) may help hasten resolution and \\nrelieve pruritus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4 Acute or chronic inflammatory disorder affecting the skin, \\nscalp hair follicles, mucous membranes, and nails (5%-\\n10%)\\n\\uf0a4 Etiology: Likely an immunologically mediated reaction; \\noral erosive lichen planus associated with hepatitis C \\n(Characteristic eruption of unknown etiology)\\n\\uf0a4 History: Uncommon in children. Family history is 10%. \\nPruritus common; oral lesions may or may not be \\nsymptomatic. Ask about Hep C risk factors (e.g., \\ntransfusions) for oral erosive LP. May be drug-induced.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4 Physical: 7 P’s\\n- Planar (flat-topped)        - Pruritic (intense)\\n- Purple                                - Polygonal\\n- Papules                             - Penile (commonly affected)\\n- Prolonged course (up to 18 mo; longer in some case)\\n\\uf0a4 Distributed on flexor surfaces, penis (glans), mouth (lacy white \\npatches or erosions – Wickham striae)\\n\\uf0a4 Koebner phenomenon: appearance of lesions at sites of trauma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4 Course: May resolve spontaneously or have chronic \\ncourse (esp. oral LP); increase risk of oral SCC in oral LP\\n\\uf0a4 DDx: Drug reaction, Pityriasis rosea, Psoriasis\\n\\uf0a4 Investigations: Skin biopsy if unsure of diagnosis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4 Management\\n\\uf0a4 Topical: Mild to high potency steroid bid for 2 weeks; intralesional if \\nhypertrophic/thick. Triamcinolone acetonide in adhesive base for oral lesion\\n\\uf0a4 Systemic: (if severe and generalized)\\n- Prednisolone; a 4 weeks course starting at 1 mg/kg q.d. \\n- Retinoids\\n- UV therapy\\n- Cyclosporine\\n- Metronidazole 500 mg po bid * 6 wk, sedative antihistamines for itching'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Common (1%-2% prevalence), chronic, recurrent \\ninflammatory skin disease with unpredictable course.\\n\\uf0a4 Onset: any age, peaks late twenties\\n\\uf0a4 Etiology: Genetic & environment factors; abnormal \\nepidermal differentiation and hyperproliferation initiated \\nand maintained primarily by T-cell\\n\\uf0a4 History: Visible itchy red plaques with increase skin scaling \\nand peeling. May have joint pain (7-20%). May have \\npreceding URTI (Streptococcus infection). Worsened by \\nsmoking, alcohol & stress, physical trauma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Physical: Most common chronic plaque psoriasis. \\nCharacteristic sharply defined, erythematous plaques \\nwith silvery-white scale; distributed over extensor surfaces \\n(elbows, knees), scalp, sacrum and other sites\\n- Nail psoriasis: Pitting, thickening, “oil-drop”, lifting of nail \\nplate off of distal nail bed (onycholysis)\\n- Koebnerization = new lesions occur at sites of skin trauma \\n(as with lichen planus)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Variants: Vulgaris, palmoplantar, guttate (may follow \\nstreptococcal pharyngitis), erythrodermic, pustular, \\ninverse (affects folds and flexor surfaces)\\n\\uf0a4 Drug may precipitate or exacerbate psoriasis: \\nAntimalarials, clonidine, indomethacin, iodine, lithium, \\nNSAIDS, quinidine, some beta-blockers, steoids\\nwithdrawal and terfenadine.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Plaques type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Erythroderma)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Guttate type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Palmoplantar)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Inverse type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 In 10-20% may be associated with psoriatic arthritis, most \\ncommonly of the small joints of the hands and feet; \\nrequires systemic Tx\\n\\uf0a4 Investigation: Clinical diagnosis; skin biopsy if uncertain\\n\\uf0a4 DDx: Drug reaction, eczema. Lichen planus, pityriasis\\nrubra pilaris'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Topical\\n- Steroids; Fast, temporary relief (atrophy, telangiectasia)\\n- Calcipotriol ointment, 100g bid. on weekdays as \\ntolerated + topical steroid bid., weekends\\n- Tazarotene 0.05%, 0.1% cream qhs\\n- Tar preparations; low cost, effective (limited by odor, \\nirritation, clothing stains)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Systemic\\n- Methotrexate; Folic acid antagonist that inhibits DNA \\nsynthesis & causes immunosuppression (Bone marrow and \\nhepatic toxicity, nausea, anorexia, fatique, oral ulceration)\\n- Cyclosporine; Immunosuppressant that inhibits IL-2 \\nproduction & thus reduces T-cell proliferation (Renal toxicity, \\nhypertension)\\n- Acitretin; Inhibits cell replication by modulating cellular \\ndifferentiation within the epidermis. May combine with PUVA \\nor UVB.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Phototherapy\\n- UVB (narrowband ultraviolet B); administer 2-5 times per \\nweek.\\nor\\n- PUVA; Interferes (Psoralen plus ultravioletA) with DNA \\nsynthesis, decreases cellular proliferation, and induces \\napoptosis of cutaneous lymphocytes leading to localized \\nimmunosuppression. Administer 3 times per week until clear, \\nthen tapered. (Skin cancer development, photoaging)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Newer Biological Agents\\n- Alefacept ; Fusion protein of Fc receptor of human lgG1 and LFA3. (IM; \\nwhen effective long remissions; monitoring of CD4 q wk; slow onset)\\n- Efalizumab ; Humanized monoclonal antibody to CD11 a; blocks LFA-1/ \\nICAM interaction. (SC; rapidly effective, but rebound; risk of \\nthrombocytopenia)\\n- Etanercept ; Fusion protein directed against soluble TNFa(SC; effective for \\npsoriasis & psoriatic arthritis; rapid onset; no monitoring; use +/- MTX)\\n- Infliximab ; Chimeric monoclonal antibody against TNFa (IV; Fast onset and \\nvery effective; must do PPD; infusion reactions.\\n- Adalimumab ; Fully humanized anti-TNF monoclonal antibody (SC; newest \\nof the biologics, still being studied.\\nNote TNF drugs avoid or use with caution in presence of CHF, demyelination \\ndisorders. Increased risk of opportunistic infections.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Scalp; 10% salicylic acid in mineral oil qhs, tar shampoo \\nqd, steroid lotion, calcipotriol lotion.\\n\\uf0a4 Nails; Intradermal triamcinolone acetonide injections \\n(painful), methotrexate, new biologics.\\n\\uf0a4 Generalized psoriasis (>10% BSA) benefits from systemic \\ntherapy, best administered by an experienced physician'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4 Acquired skin disorder characterized by well-defined \\nareas of complete epidermal depigmentation; various \\npathogenesis theories; likely a large autoimmune \\ncomponent\\n\\uf0a4 History; Asymptomatic: 50% present before age 20, 1-2% \\naffected, rare in infancy & old age\\n\\uf0a4 Associated with immune disorder; therefore workup for \\nthyroid disease, diabetes, pernicious anemia and other \\nautoimmune diseases occasionally indicated'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4 Physical: Stark white patch with well-demarcated border; \\nhair in vitiligo patches appears white or gray\\n\\uf0a4 Increased risk of sunburn and skin cancer in amelanotic\\nareas\\n\\uf0a4 Investigations; Wood’s lamp accentuates areas of vitiligo\\n& helps determine extent; consider TSH and fasting blood \\nglucose\\n\\uf0a4 DDx; Leprosy, pityriasis alba, tinea vesicolor, tuberous \\nsclerosis, nevus depigmentosus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4 Management\\n- Mainly for cosmetic, psychological burden\\n- Topical steroids and new topical immunomodulators (tacrolimus & pimecrolimus), \\nPUVA, NB-UVB, phototherapy\\n- Camouflage makeup\\n- Note that facial and more proximal lesions respond better than acral lesions\\n- Surgical transplants can be considered in stable vitiligo\\n- If extensive, can consider bleaching of nonaffected areas to result in total white \\ncolor\\n- -Advise; importance of sun protection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4 Etiology: Self-limited viral infection of skin caused by \\npoxvirus affecting mainly children.\\n\\uf0a4 Immunocompromised patients (e.g., HIV) may develop \\nmore widespread and larger lesions\\n\\uf0a4 History: Asymptomatic; occasional perilesional pruritus, \\nvery common in children. Spread by direct contact or \\nautoinoculation. Lesions tend to be more numerous and \\nspread rapidly in patients with atopic dermatits.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4 Physical: 2- to 6- mm firm, flesh colored, dome-shaped, \\numbilicated pearly papules; most common affected sites –\\ntrunk and face of children, genital/inner thigh of sexually \\nactive adults\\n\\uf0a4 Molluscum papules in a child in the periorbital region. \\nLesions can be spread by picking and scratching. Lesions \\nwill be resolve with development of cellular immunity. \\n\\uf0a4 Course: lesions typically involute spontaneously within 9-12 \\nmo; may develop adjacent eczema (10%)\\n\\uf0a4 Investigation: clinical diagnosis, biopsy if uncertain\\n\\uf0a4 DDx: BCC, milia, other infection, warts'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4 Management\\n- Observation\\n- Liquid Nitrogen Cryotherapy\\n- Curettage: may be uncomfortable\\n- Papule incision with a scalpel blades or at home sharp fingernail and expression of \\ncontents\\n- Topical cantharidin 0.7%: Blistering will occur\\n- Imiquimod cream, Tretinoin cream\\n- In children with widespread involvement, may consider oral cimetidine (40 \\nmg/kg/d ) for 2 mo.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tinea Versicolor)\\n\\uf0a4 Etiology : Common superficial cutaneous fungal infection \\ncaused by Malassezia furfur (Pityrosporum orbiculare), The \\norganism is part of normal skin\\n\\uf0a4 History : May itch but usually asymptomatic, young adults \\ntypically affected (years of higher sebaceous activity) ; \\ncommonly recurs (40-60%) ; more common in hot and humid \\nenvironments.\\n\\uf0a4 Cushing disease, pregnancy, mulnutrition, corticosteroid \\ntherapy, immunosuppression, oral contraceptives may lower \\nresistance, allowing this normally non-pathogenic resident \\nyeast to poliferate'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tinea Versicolor)\\n\\uf0a4 Physical : Round to oval macules and patches on the \\ntrunk extending to the upper arms, neck, abdomen; \\ndifferent colors: White, orange-brown, dark-brown; very \\nfine scale; postinflammatory hypopigmentation is often \\nnoted rather than initial erythema.\\n\\uf0a4 Investigations: KOH test reveals diagnostic “spaghetti & \\nmeatballs” (hyphae & spores); Wood’s lamp shows \\nyellow-brown fluorescence. Skin biopsy if diagnosis \\nuncertain.\\n\\uf0a4 DDx : Tinea corporis, vitiligo, psoriasis.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)\\n\\uf0a4 Management\\n\\uf0a4 Topical or systemic treatment.\\n\\uf0a4 Nizoral shampoo (ketoconazole 2%) applied onto dampened \\ntrunk skin, lathered for 5 min before rinsing, x 3 d.\\n\\uf0a4 Topical selenium sulfide 2.5% shampoo applied for 15 min x 3 d.\\n\\uf0a4 Topical nizoral cream 2% (ketoconazole) bid x 2 wk.\\n\\uf0a4 Systemic ketoconazole 200 mg po qd x 5 – 7 d or fluconazole \\n400 mg x 1. Postinflammatory hypopigmentation may persist for \\n6 – 12 mo.\\n\\uf0a4 Even with treatment, tendency to recur in summer.\\n\\uf0a4 Zinc pyrithione soap lather may be applied to the body 1 – 3 \\ntimes weekly for prevention.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4 Dermatophyte digest and invade keratin then infect skin, \\nnails and hair; incubation period = 1-3 weeks\\n\\uf0a4 Trychophyton, Microsporum, Epidermophyton species \\ncommonly involved.\\n\\uf0a4 Risk Factors; Hot, humid environment, sweating or \\nmaceration of the skin, occlusive footwear, Diabetes \\nmellitus, immunosuppression\\n\\uf0a4 History: Asymptomatic; occasionally mild pruritus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4 Physical; Scalp hair and general body surfaces mostly \\naffected during childhood; hand, foot or nail infections \\nare more common after puberty\\n\\uf0a4 Immunologic response to a dermatophyte infection may \\nresult in a dermatophytid reaction: Vesicular eruption on \\nacral surfaces, especially the palms'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4 Investigations; Skin scraping analysis with KOH prep –\\nSeptate hyphae branching at various angles are seen; \\nfungal culture\\n\\uf0a4 DDx; Eczema, granuloma annulare, psoriasis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea Capitis\\n\\uf0a4 Caused by invasion of stratum corneum and hair shaft with fungal \\nhyphae.\\n\\uf0a4 Four clinical infection patterns;\\n- Seborrheic dermatitis type- Diffuse, patchy scale on scalp\\n- Black dot pattern- hyphae invade hair shaft. Hair then broke at \\nscalp surface. Broken shaft like black dots. Round area of alopecia \\nwithout inflammation\\n- Inflammation tinea capitis (kerion)- Deep boggy round masses with \\npustules, surface exudate\\n- Pustular- Pustules areas without scaling, significant hair loss may be \\npresent, look like scalp bacterial infection.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic dermatitis type – Tinea\\nCapitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Black dot pattern – Tinea Capitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Inflammation tinea capitis (kerion) –\\nTinea Capitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea Capitis\\n\\uf0a4 Management\\n- Examine sibling and household members, clean or discard \\ncontaminated objects.\\n- Griseofulvin; usually 6-12 weeks\\n- Itraconazole and fluconazole; taken for 4-8 weeks. A single dose of \\n150 mg once weekly for 4 weeks also be effective for older children\\n- Shampoo with selenium sulfide 1% or ketoconazole every other day \\nfor the first 2 weeks, then twice weekly throughout course of rest of \\noral therapy. Shampoo is left for 5 min\\n- Consider suppression kerion inflammation with prednisolone 1-2 \\nmg/kg qd or intralesional triamcinolone 10 mg/cc'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4 Common form of septal panniculitis that is usually a reactive skin response to \\nan associated trigger\\n- Infections; Bacterial (e.g., streptococcal pharyngitis), microbacterial\\n(tuberculosis)\\n- Drugs; e.g., oral contraceptives, sulfonamides\\n- Sarcoidosis\\n- Inflammatory bowel disease\\n- Behcet disease\\n- Malignancy\\n- - Pregnency'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4 History; Lesions may be associated with fever, malaise, \\nleg edema and arthralgia. Resolution after 2-6 wk\\n\\uf0a4 Physical; painful, dull, erythematous nodules 1-5 cm in \\ndiameter, located on anterior lower legs of young \\nwoman. No ulceration, discharge or scarring\\n\\uf0a4 Investigation; Through review of systems: CBC, UA, chest \\nx-ray and throat swab\\n\\uf0a4 DDx; Insect bite reaction, erysipelas, urticaria'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4 Management\\n- Investigate for and treat underlying cause.\\n- Most patients benefit from bed rest, applying ice or cool \\ncompresses, elevating legs & NSAIDs\\n- Less common Tx choice; Oral prednisolone, colchicine, \\ndapsone'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4 An inflammatory condition of degenerative collagen. \\nWhen present, it is often associated with diabetes\\n\\uf0a4 Lesions usually develop slowly and are often \\nasymptomatic, onset may occur at any age but the \\ndisease most common starts at 3rd – 4th decade. About \\n75% of those affected are women'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4 Physical Findings\\n\\uf0a4 Lesion are usually limited to the anterior shins but may be seen \\non calve and thighs, and rarely on the arms, hands, feet and \\nscalp.\\n\\uf0a4 They begin as round, violaceous patches and slowly expand. \\nThe advancing border is red, and the central area turns a \\ncharacteristic orange-yellow brown. The central area atrophies \\nand shows a shiny, waxy surface with prominent telangiectasias.\\n\\uf0a4 Ulceration may occur, particulary after trauma, in about 15% of \\ncases. These ulcers are exquisitely tender.\\n\\uf0a4 The number or severity of lesions or ulcerations has not been \\ncorrelated with the degree of diabetic control.\\n\\uf0a4 The course is unpredictable. Lesions usually heal with atrophic \\nscarring, or can be chronic and recurrent.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4 Treatment\\n\\uf0a4 Topical and intralesional steroids slow the inflammation but may \\npromote further atrophy. Middle- to high-potency \\ncorticosteroids can be used under occlusion.\\n\\uf0a4 Intralesional injections of triamcinolone acetonide 10 mg/mL \\ncanbe helpful.\\n\\uf0a4 A short course (5-6 weeks) of oral corticosteroids can be \\nconsidered if disease activity and symptoms are severse, but this \\nis rarely the case.\\n\\uf0a4 Pentoxifylline (Trental) 400mg t.i.d. has been advocated by \\nsome and has been used in combination with low-dose aspirin \\nfor ulcerating necrobiosis lipoidica. \\n\\uf0a4 Skin grafting can be performed for extensive disease.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d Common idiopathic benign epidermal growth\\n\\uf07d Common in fourth decade\\n\\uf07d Males and females equally affected\\n\\uf07d More common in fair skin\\n\\uf07d Possibly autosomal dominant\\n\\uf07d Gradual development; occasionally pruritic or sore'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d Well circumscribed  epidermal growth, raised lesions\\n\\uf07d Waxy round-oval papules and plaques with verrucous or \\ncrusted surface. Sharp border\\n\\uf07d “Stuck on” appearance \\n\\uf07d Starts as light brown macule \\n larger and verrucous with \\ntime\\n\\uf07d Also, smooth-surfaced lesions contain dark or light round \\nhorn pearls embedded in the lesion or protruding from the \\nsurface. \\n\\uf07d Variably pigmented and size\\n\\uf07d Most commonly: trunk, neck, arms, scalp; wide range of size'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf0a4 Leser-Trelat sign: Sudden, eruptive seborrheic keratoses in \\nelderly individuals, often with inflammatory base may be \\na sign of an associated internal (stomach cancer & \\nothers) malignancy as part of paraneoplastic syndrome'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf0a4 Investigation: Clinical diagnosis; skin biopsy if uncertain.\\n\\uf0a4 DDx: AK, BCC, lentigo, melanoma, nevus, skin tag, wart'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d Treatment may be indicated for symptomatic lesions which \\nare inflamed, irritated or bleeding.\\n\\uf07d THERAPIES\\n◦ Cryotherapy; for flat to minimally raised lesions. \\n◦ Light cautery/electrodessication \\n◦ Shave excision\\n◦ Laser\\n\\uf096 Not effective for thicker lesions \\n\\uf096 Ruby (694nm)\\n\\uf096 Alexandrite (755nm)\\n\\uf096 CO2\\n\\uf096 Erbium'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d Most common precancerous lesions in humans, and more \\nprevalent in fair-skinned individuals who tan poorly and burn \\neasily.\\n\\uf07d Found in sun-exposed skin \\n◦ Face, ears\\n◦ Neck, forearms\\n◦ Dorsal hands\\n\\uf07d Outdoor occupations, ionizing radiation, \\nand arsenic exposure'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d Common in skin type I-III\\n\\uf07d Secondary to cumulative keratinocyte damage\\n\\uf07d Atypical keratinocytes confined to epidermal basal layer\\n\\uf07d < 1% progress to skin cancer (squamous cell carcinoma, SCC)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf0a4 Clinical appearance\\n- Slightly erythematous, rough, scaly papules on sun-exposed \\nareas\\n- May be difficult to see, but often feel rough: Palpation is \\nessential to diagnosis.\\n- Most commonly in the elderly\\n- DDx: BCC, Bowen disease, SCC\\n- Investigation: Biopsy if recurrent, unresponsive to treatment, \\nor pronounced hyperkeratosis and induration'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d Treatment options\\n◦ Topical\\n\\uf096 5%  5-flourouracil  (Carac, Efudex) applied bid for 2-4 \\nwk\\n\\uf096 5% Imiquimod (Aldara) applied three to five times \\nweekly for 12 wk\\n\\uf096 Expect \\n erythema, irritated, inflamed and crusting; \\nfollow-up visit in 1-2 wk to evaluate severity of side \\neffects'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n◦ Liquid Nitrogen Cryotherapy for limited lesions\\n◦ Electrodesication and curettage, CO2 laser\\n◦ Dermabrasion\\n◦ Chemical peel (for numerous AKs)  \\n\\uf096 Serial medium depth \\n TCA\\n◦ Light Therapy\\n\\uf096 PDT with ALA. Pulsed CO2\\nSun-awareness and protection advice'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Most common cutaneous malignancy derived from stem \\ncells of epidermis. Locally invasive, slow-growing, rarely \\nmetastasizes (unless patients is immunocompromised)\\n\\uf0a4 Etiology: Chronic UV exposure (Cumulative sun exposure \\nis primary risk factor), radiation, immunosuppression, \\ngenetics (e.g., nevoid basal cell carcinoma syndrome)\\n\\uf0a4 History: Persistent, nonhealing papule or nodule that \\nulcerates or bleeds (beefy-red smooth erosive nodule). \\nCommon in elderly (most common after 40) Caucasians.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Physical: Pearly papule or nodule with telangiectases, \\nrolled border; central crust or ulceration.\\n\\uf0a4 Distributed mostly on sun-exposed areas, i.e., head and \\nneck (85%). Variants: Superficial, nodular, sclerosing\\n(morpheaform), pigmented\\n\\uf0a4 DDx: Melanoma, nevus, SCC\\n\\uf0a4 Investigations: Biopsy must be performed to confirm \\ndiagnosis and classify subtype.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Physical Findings\\n- Nodular BCC: Most common variant. A pearly white, \\nalmost translucent, dome-shaped papule with overlying \\ntelangiectasias. Papule or nodule enlarges slowly, may \\nbecome flattened in center or may develop a raised, rolled, \\ntranslucent border. Frequently ulcerates, bleeds, becomes \\ncrusted in center'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n- Pigmented BCC: contains melanin, may therefore \\nresemble melanoma\\n- Superficial BCC: least aggressive form. More commonly \\non trunk, extremities. Circumscribed, round to oval, red, \\nscaling plaque resembles eczema, psoriasis, \\nextramammary Paget disease or Bowen disease\\n- Sclerosing BCC : Most subtle and least common variant. \\nSmooth, pale white to yellow papules. Resembles scar \\ntissue. Borders may be difficult to discern. Higher rate of \\nrecurrence'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nNodular BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nPigmented BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nSuperficial BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nSclerosing BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Management\\n- Advise that metastases and death are extremely rare. Vast \\nmajority cause no major problem, but should be treated\\n- Without treatment, BCCs persist, enlarge, ulcerate, invade, \\ndestroy surrounding structures \\n- Tx options depend on histological subtype and location: \\nLiquid nitrogen cryotherapy (requires experience), \\ncurettage & electrodessication (most common Tx), excision, \\nMohs micrographic surgery, imiquimod cream for superficial \\nsubtype, 5-FU, CO2 laser, radiation therapy\\n- Advise on sun protection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Electrosurgery of obvious tumor. The 5 year cure rate \\napproach 92%\\n\\uf0a4 Primary excision is preferred for non-facial, well-defined \\nnodular. The 5 year rate approach 90%\\n\\uf0a4 Mohs microsurgery is a highly specialized, tissue-sparing \\nmethod of excision used for difficult tumors with \\ncontiguous growth. It is also used for recurrent BCC, \\nhistological  aggressive forms of BCC, such as sclerotic \\nBCCs, and tumors in anatomically important locations \\nsuch as around eyes, nasal alar, mouth and ears.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Radiation therapy may be useful for difficult-to-treat \\ntumors, such as eyelids, and for patients unable to \\ntolerate surgery. The 5 year cure rates are roughly 90%\\n\\uf0a4 Photodynamic therapy is an evolving chemotherapeutic \\nmodality for superficial BCC\\n\\uf0a4 Topical imiquimod 5% cream is an immune response \\nmodifier shown to be about 85% effective or better for \\nsuperficial BCC. It is less effective for nodular BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n2nd most common form of skin cancer (after BCC) arising in sun \\nexposed areas in elderly; due to malignant keratinocytes with \\nmetastatic potential.\\n\\uf0a4 Etiology : Chronic UV-damage is the primary cause, \\nimmunosuppression, burns leg ulcers, chemical carcinogens \\n(e.g., tar), HPV; can occur in discoid lupus, lichen sclerosus, \\n& any scarring processes.\\n\\uf0a4 History : Slow-growing, nonhealing scaly papule on sun-\\nexposed area of head, neck, dorsal hands, and forearms; \\nalso affects mucous membranes (lower lip: M >> F, smokers, \\n10% - 15% metastatic rare); rare in dark skin.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n\\uf0a4 Physical : Firm indurated papule, plaque, or nodule with \\nadherent rough scale on sun-exposed areas. Normally with \\nnecrotic crusted center. Removal of crust reveals central \\ncavity filled with necrotic keratin debris.\\n\\uf0a4 Actinic keratosis is considered a precursor lesion; actinic \\ncheilitis is the precursor on lip.\\n\\uf0a4 Ultimately, tumors metastasize, via the lymphatics to other \\norgans\\n\\uf0a4 Investigations : Biopsy (to mid-dermis) for confirmation.\\n\\uf0a4 DDx : AK, BCC, SK, amelanotic melanoma, wart.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n\\uf0a4 Management\\n\\uf0a4 Wide local excision with histologic confirmation of margins.\\n\\uf0a4 Lymp node biopsy indicated for suspected nodal disease\\n\\uf0a4 Liquid nitrogen cryotherapy\\n\\uf0a4 Mohs micrographic surgery\\n\\uf0a4 Less commonly topical imiquimod or radiation\\n\\uf0a4 Advide on sun protection.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4 Etiology : Melanocyte-derived skin cancer. May arise within \\na previously existing nevus or dysplastic nevus, but ~ 70% \\narise de novo \\n\\uf0a4 History : Risk factors\\n\\uf0a4 Fair complexion: Red/blonde hair, blue/green eyes, tendency to \\nfreckle and burn.\\n\\uf0a4 Sun exposure, particularly blistering sunburns during childhood.\\n\\uf0a4 Personal of family history of melanoma; Genes involved in some \\ncases: CDKN2A, BRAF.\\n\\uf0a4 Giant congenital melanocytic nevi or multiple dysplastic nevi.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4 Physical: Pigmented macule or plaque with some or all of the \\nfollowing features \\nABCDE of melanoma: \\n- Asymmetry\\n- Borders (irregular)\\n- Color variegation\\n- Diameter (> 6mm)\\n- Evolution (lesion change by history)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\nClassically divided into subtypes based on clinical and histopathologic features:\\n1. Superficial spreading malignant melanoma – 60%-70% of melanomas.\\n2. Nodular melanoma.\\n3. Acral-lentiginous melanoma – Most common form in blacks, Asians, and \\nHispanics, mostly on volar skin of the palms or soles and the nailbeds.\\n4. Lentigo maligna melanoma – Develops from a lentigo maligna, usually on the \\nface of elderly, slow-growing.\\n5. Amelanotic melanoma – Pink-red.\\n6. Rare variants.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Superficial spreading malignant \\nmelanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Nodular melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acral-lentiginous melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lentigo maligna melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Amelanotic melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4 Most common sites of local and/or regional metastases-\\nDraining lymph node basins and the skin between the \\nprimary site and the lymph nodes.\\n- Most common sites of systemic metastases – Lung, Liver, \\nbrain (#1 cause of death), bone, and gastrointestinal tract. \\n\\uf0a4 Investigations: Dermoscopy (ABCD rule), excisional biopsy if \\nmelanomais suspected\\n\\uf0a4 Most important prognostic indicator is maximal thickness of \\ntumor invasion on biopsy (Breslow depth in mm)\\n\\uf0a4 DDx: BCC, blue or dysplastic nevus, SK'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4 Management\\n- Wide surgical excision; based on Breslow depth: 5 mm for \\nmelanoma in situ, 1 cm for melanoma <1mm, 2 cm for \\nmelanoma >1mm\\n- Sentinel lymph node biopsy depending on clinical\\n- Adjuvant high-dose interferon & IL-2 may provide benefit for \\nmetastatic disease\\n- Perfusion chemotherapy for extremity melanoma\\n- Radiation'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 Chronic inflammatory dermatosis affecting 10%-20% of \\nchildren (esp. infants and young children)\\n\\uf0a4 Etiology: Cutaneous immune dysfunction; IgE-mediated; \\ngenetics. Strong associated with personal and family \\nhistory of atopy (eczema, asthma)\\n\\uf0a4 History: “Pruritus” is a hallmark (“the itch that rashes”). \\nAggravating factors: sweating, contact sensitivity, \\nsecondary infection, wool, food allergy, stress/anxiety.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 Acute: Erythematous, excoriated, scaling patches and plaques; \\nmore lichenification in chronic forms.\\n\\uf0a4 Distribution:\\n- Infants: Cheeks, forehead, scalp, extensor surfaces of extremities\\n- Child: Flexural surfaces- antecubital and popliteal fossae, wrists, \\nankles\\n- Adults: Hands, flexural. The prominent finding is lichenification; this \\nindicates a long – standing problem.\\n\\uf0a4 Lesions can be secondarily infected with staphylococcal \\norganisms: impetigo'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nInfants: Cheeks, forehead, scalp, extensor surfaces of extremities'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nChild: Flexural surfaces- antecubital and popliteal fossae, wrists, ankles'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nAdults: Hands, flexural. The prominent finding is lichenification\\n; this indicates a long – standing problem'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 DDx: Contact dermatitis, psoriasis, seborrheic dermatitis\\n\\uf0a4 Investigation: Allergy or RAST testing of little value (Patch \\ntest if dermatitis pattern changes or refractory to \\ntreatment. \\n\\uf0a4 Diagnosis Requires: History of an itchy skin condition (or \\nparental report of scratching/rubbing by the child)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 Plus ≥3 of :\\n1. History of involvement of skin crease (antecubital, popliteal, anterior \\nankles or around the neck) or cheeks in children < 10 years\\n2. Personal history of asthma or hay fever (or history of atopic disease \\nin 1st degree relative if < 4 years of age)\\n3. History of generalized dry skin in the past year.\\n4. Visible flexural dermatitis (or eczema on the cheeks/forehead and \\nouter limbs in children < age 4 years)\\n5. Onset under the age of 2 (do not use as criterion if patient is < age 4 \\nyears)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 Minor, less specific feature: \\n- xerosis, ichthyosis, palmar hyperlinearity, keratosis pilaris. \\nImmediate type 1 skin test responses, dermatitis of hands \\nand feet, cheilitis, nipple eczema, increased susceptibility to \\ncutaneous infection, perifollicular accentuation'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 Management\\n- Elimination of precipitating irritants: avoid wool and synthetic \\nfabrics; wear cotton clothes, humidifier at home; dietary \\nrestriction if specific verified food allergy; stress reduction.\\n- Skin hydration: Baths with emollients, apply thick \\nnonfragranced emollient immediately after bath.\\n- Topical steroids: 1% hydrocortisone ointment bid to face \\nand folds, midpotency steroids bid to other effected areas; \\nointments more occlusive and more effective than creams.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4 Management\\n- Steroid-sparing topical immunomodulators can be used bid in \\nchildren > 2 yr: Pimecrolimus cream – mild to moderate eczema. \\nTacrolimus – moderate to severe eczema.\\n- Oral antihistamines with sedative effect may offer symptomatic \\nrelief of the associated pruritus, e.g., hydroxyzine (3-5 mg/kg/d divided \\ntid/qid)\\n- If secondarily infected: antibiotic therapy\\n- If patients refractory to conventional therapy, other systemic Tx\\nchoices include: PUVA or UVB light therapy, systemic steroids (short \\ncourses), methotrexate, cyclosporine: usually administered by \\ndermatologist')]"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "filtered=filter_to_minimal_chunk(extracted_data)\n",
    "filtered"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "51cfd8eb",
   "metadata": {},
   "outputs": [],
   "source": [
    "#split chunk\n",
    "def split(minimal_doc):\n",
    "    text_slitter=RecursiveCharacterTextSplitter(\n",
    "        chunk_size=500,\n",
    "        chunk_overlap=20\n",
    "        \n",
    "    )\n",
    "    text_chunk= text_slitter.split_documents(minimal_doc)\n",
    "    return text_chunk\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "5c77334c",
   "metadata": {},
   "outputs": [],
   "source": [
    "text_chunk=split(filtered)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "c2233a58",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Common Skin Disease\\nSurangkana Veeranawin, MD\\nMSc, Queen Mary University of London\\nMmed, University of Sydney\\nDipDerm RCPS(Glas.)\\nDiplomate American Broad of Aesthetic Medicine (ABAM)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne Vulgaris\\n\\uf0a4 Inflammatory disorder of pilosebaceous follicle with a 90% \\nprevalence in adolescence and young adulthood.\\n\\uf0a4 History: often asymptomatic lesions (especially comedone), \\nalthough can be tender (nodules)\\n\\uf0a4 Physical: two types of lesions, predominantly affect face, \\nneck, chest and back\\n- Noninflammatory; open(“black head”) and closed (“white \\nhead”) comedones\\n- Inflammatory; papules, pustule, cysts, nodule: deep lesions \\n(leave scars)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne Vulgaris\\n\\uf0a4 4 Major components\\n• Abnormal follicular keratinization: follicular wall cells fail to \\ndesquamate to the surface in the normal manner.\\n• Sebum over production secondary to androgen\\n• Propionibacterium acnes infection; they grow in the \\nsebum-cell mixture.\\n\\uf0a7 Inflammation\\n\\uf0a4 Other components; genetic factors, occlusive cosmetic \\nagents, medication (steroids, ACTH, androgens, lithium, \\nantiepileptics, oral contraceptives), diseases (PCOS, \\nCongenital Adrenal Hyperplasia)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nTreatment Strategies\\n- Retinoid for clearing pores and comedones for all acne \\nconditions\\n- Small inflammatory lesions \\uf0e0Topical Benzoyl Peroxide (BP) &  \\nTopical Antibiotic\\n- Large inflammatory lesions \\uf0e0 Oral antibiotic'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nMild \\uf0e8\\uf0e8 Topical Only\\n\\uf0a4 Decrease follicular plugging\\n• Retinoid \\n• Nightly\\n• Adapalene (Differin); if can not tolerate retinoid\\n• Salycilic acid wash/scrub\\n\\uf0a4 Decrease P. Acne\\n• Topical Antibiotic \\n• Clindamycin  \\n• Benzoyl peroxide; bacterialcidal, decrease sebum/oil'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nModerate or nonresponsive to topical\\n\\uf0a4 Add oral antibiotic\\n• Tetracycline\\n250 – 500 mg twice/day\\n• Minocycline \\n50 – 100 mg twice/day\\n• Doxycycline\\n50 – 100 mg twice/day\\n\\uf0a4 Add chemical peel  \\uf0e0 Salicylic or Jessner'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\n\\uf0a4 Other treatment\\n- comedone extraction, intralesional cortisone injection (for \\npapulonodules, cysts), oral contraceptives (esp. anti-\\nandrogenic such as cyproterone acetate), photodynamic \\ntherapy, spironolactone (reduces androgen production; 50 \\n– 200 mg/day), dermabrasion\\n- Patients should be forewarned of acne exacerbations in \\nthe first month of systemic therapy as deep-seated acne \\ncomes to the surface. Also, systemic therapy can required 6 \\nwk before benefits are noted'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4 Chronic vascular & acneiform disorder\\n\\uf0a4 Common chronic inflammatory disorder of pilosebaceous units \\nand vasculature of the face\\n\\uf0a4 Role of Demodex mite controversial\\n\\uf0a4 Increase reactivity of capillaries \\uf0e8\\uf0e8\\uf0e8Flushing\\uf0e8\\uf0e8\\uf0e8ultimately \\nleading to telangiectasia'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4 Easy and recurrent flushing\\n\\uf0a4 Sensitive skin\\n\\uf0a4 More common in fair skin\\n\\uf0a4 May complain of dry and gritty eyes\\n\\uf0a4 Female > male\\n\\uf0a4 Peak incidence 30-50 yr'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\nEXACEBATE BY\\n\\uf0a4 Heat,rapid change in temperature\\n\\uf0a4 Sun exposure\\n\\uf0a4 Cold\\n\\uf0a4 EtOh\\n\\uf0a4 Stress\\n\\uf0a4 Spicy food\\n\\uf0a4 Hot food/beverage\\n\\uf0a4 Caffeine'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4 Clinical appearance: Erythema, telangiectases, papules, \\nand pustules of central face; no comedones in contrast \\nto acne.\\n\\uf0a4 Erythema of the nose is highly characteristic of rosacea\\n\\uf0a4 Accompany with, sebaceous hyperplasia, seborrheic\\ndermatits & facial lymphedema more common'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4 Predominantly central face\\n- Forehead\\n- Cheeks\\n- Nose\\n- Chin\\n- Occasionally eyelids'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4 4 Major subtypes\\n\\uf0a4 Vascular rosacea ( Erythematotelangiectatic rosacea)\\n\\uf0a4 Papulopustular rosacea\\n\\uf0a4 Ocular rosacea: gritty, conjunctival injection, styes and \\nphotophobia. (The eye is involved in about 50% of cases)\\n\\uf0a4 Nasal sebaceous hyperplasia (rhinophyma): chronic \\ninflammation may progress to rhinophyma (more common in \\nmale)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='ROSACEA'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='ROSACEA\\nRHINOPHYMA\\nPAPULOPUSTULAR'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4 Investigation\\n- Clinical diagnosis\\n- Skin biopsy to rule out lupus or sacoidosis\\n\\uf0a4 Differential Diagnosis\\n- Acne              - Lupus erythematosus - Sarcoidosis\\n- Seborrheic dermatitis     - Perioral dermatitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf07d Management\\n- Based on severity and  subtype.\\n- Lifestyle modification : Avoid triggers ; sun protection & \\navoidance.\\n- Topical antibiotic \\n\\uf096 Metronidazole 0.75% gel or 1% cream bid\\n\\uf096 Sodium sulfacetamide lotion 10% bid\\n\\uf096 Azelaic acid QD'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n- Oral antibiotic (moderate to severe cases with \\ninflammatory papulopaustular component)\\n\\uf096 Tetracycline 500 mg po BID\\n\\uf096 Minocycline 100 mg OD – BID\\n\\uf096 Doxycyline 20 mg po bid (subantimicrobial dose \\ntherapy) or 100 mg po qd-bid\\n- Isotretinoin and prednisolone for very severe cases'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n- Light therapy\\n\\uf096 Treatment of Choice \\uf0e0 IPL (400nm – 1200nm), PDL  \\n(595 nm) for telangiectases\\n\\uf096 Ablative laser (CO2) for rhinophyma\\n- Ophthalmologist to assess for ocular involvement \\n(blepharitis, conjunctivitis)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4 Acute, self-limited papulosquamous inflammatory skin \\nexanthem in 15-40 yr.\\n\\uf0a4 The primary lesion is an oval, salmon-colored, 1-10 cm \\nplaque that forms a round collarette of scale in the \\ncenter.\\n\\uf0a4 It evolves rapidly, usually beginning with patch that \\nheralds the eruption, the so-called “herald patch.\\n\\uf0a4 Clinical appearance: Scaly pink-erythematous plaques; \\npredominantly trunk affected, in “Christmas-tree” pattern'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4 Etiology: Possibly triggered by human herpes virus 7\\n\\uf0a4 History: May be pruritic or asymptomatic; preceding URTI or \\nmild constitutional symptoms\\n\\uf0a4 Lesions are found on the trunk and usually spare the face \\nand extremities\\n\\uf0a4 The number of lesions is highly variable. Plaques may extend \\nto the neck and proximal limbs\\n\\uf0a4 Numerous lesions may appear. A concentration of lesions on \\nthe groin and lower abdomen is highly characteristic, \\nespecially in children'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4 Course: Self-resolving in 6-8 weeks\\n\\uf0a4 Investigations: Clinical; scraping for KOH (R/O tinea) or \\norder RPR (R/O syphilis), or skin biopsy if uncertain.\\n\\uf0a4 DDx: Eczema, psoriasis, tinea corporis, syphilis, seborrheic\\ndermatitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4 Management\\n- Reassurance is key\\n- Symptomatic management of pruritus (e.g. mild topical \\nsteroids, antihistamines); mentholated lotion or sprays for \\nitching\\n- Erythromycin 250 mg, q.i.d or 25-40 mg/kg in four divided \\ndoses in children for 2 weeks may clear the eruption\\n- Light therapy (e.g. UVB) may help hasten resolution and \\nrelieve pruritus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4 Acute or chronic inflammatory disorder affecting the skin, \\nscalp hair follicles, mucous membranes, and nails (5%-\\n10%)\\n\\uf0a4 Etiology: Likely an immunologically mediated reaction; \\noral erosive lichen planus associated with hepatitis C \\n(Characteristic eruption of unknown etiology)\\n\\uf0a4 History: Uncommon in children. Family history is 10%. \\nPruritus common; oral lesions may or may not be \\nsymptomatic. Ask about Hep C risk factors (e.g.,'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='transfusions) for oral erosive LP. May be drug-induced.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4 Physical: 7 P’s\\n- Planar (flat-topped)        - Pruritic (intense)\\n- Purple                                - Polygonal\\n- Papules                             - Penile (commonly affected)\\n- Prolonged course (up to 18 mo; longer in some case)\\n\\uf0a4 Distributed on flexor surfaces, penis (glans), mouth (lacy white \\npatches or erosions – Wickham striae)\\n\\uf0a4 Koebner phenomenon: appearance of lesions at sites of trauma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4 Course: May resolve spontaneously or have chronic \\ncourse (esp. oral LP); increase risk of oral SCC in oral LP\\n\\uf0a4 DDx: Drug reaction, Pityriasis rosea, Psoriasis\\n\\uf0a4 Investigations: Skin biopsy if unsure of diagnosis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4 Management\\n\\uf0a4 Topical: Mild to high potency steroid bid for 2 weeks; intralesional if \\nhypertrophic/thick. Triamcinolone acetonide in adhesive base for oral lesion\\n\\uf0a4 Systemic: (if severe and generalized)\\n- Prednisolone; a 4 weeks course starting at 1 mg/kg q.d. \\n- Retinoids\\n- UV therapy\\n- Cyclosporine\\n- Metronidazole 500 mg po bid * 6 wk, sedative antihistamines for itching'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Common (1%-2% prevalence), chronic, recurrent \\ninflammatory skin disease with unpredictable course.\\n\\uf0a4 Onset: any age, peaks late twenties\\n\\uf0a4 Etiology: Genetic & environment factors; abnormal \\nepidermal differentiation and hyperproliferation initiated \\nand maintained primarily by T-cell\\n\\uf0a4 History: Visible itchy red plaques with increase skin scaling \\nand peeling. May have joint pain (7-20%). May have \\npreceding URTI (Streptococcus infection). Worsened by'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='smoking, alcohol & stress, physical trauma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Physical: Most common chronic plaque psoriasis. \\nCharacteristic sharply defined, erythematous plaques \\nwith silvery-white scale; distributed over extensor surfaces \\n(elbows, knees), scalp, sacrum and other sites\\n- Nail psoriasis: Pitting, thickening, “oil-drop”, lifting of nail \\nplate off of distal nail bed (onycholysis)\\n- Koebnerization = new lesions occur at sites of skin trauma \\n(as with lichen planus)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Variants: Vulgaris, palmoplantar, guttate (may follow \\nstreptococcal pharyngitis), erythrodermic, pustular, \\ninverse (affects folds and flexor surfaces)\\n\\uf0a4 Drug may precipitate or exacerbate psoriasis: \\nAntimalarials, clonidine, indomethacin, iodine, lithium, \\nNSAIDS, quinidine, some beta-blockers, steoids\\nwithdrawal and terfenadine.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Plaques type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Erythroderma)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Guttate type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Palmoplantar)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Inverse type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 In 10-20% may be associated with psoriatic arthritis, most \\ncommonly of the small joints of the hands and feet; \\nrequires systemic Tx\\n\\uf0a4 Investigation: Clinical diagnosis; skin biopsy if uncertain\\n\\uf0a4 DDx: Drug reaction, eczema. Lichen planus, pityriasis\\nrubra pilaris'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Topical\\n- Steroids; Fast, temporary relief (atrophy, telangiectasia)\\n- Calcipotriol ointment, 100g bid. on weekdays as \\ntolerated + topical steroid bid., weekends\\n- Tazarotene 0.05%, 0.1% cream qhs\\n- Tar preparations; low cost, effective (limited by odor, \\nirritation, clothing stains)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Systemic\\n- Methotrexate; Folic acid antagonist that inhibits DNA \\nsynthesis & causes immunosuppression (Bone marrow and \\nhepatic toxicity, nausea, anorexia, fatique, oral ulceration)\\n- Cyclosporine; Immunosuppressant that inhibits IL-2 \\nproduction & thus reduces T-cell proliferation (Renal toxicity, \\nhypertension)\\n- Acitretin; Inhibits cell replication by modulating cellular \\ndifferentiation within the epidermis. May combine with PUVA \\nor UVB.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Phototherapy\\n- UVB (narrowband ultraviolet B); administer 2-5 times per \\nweek.\\nor\\n- PUVA; Interferes (Psoralen plus ultravioletA) with DNA \\nsynthesis, decreases cellular proliferation, and induces \\napoptosis of cutaneous lymphocytes leading to localized \\nimmunosuppression. Administer 3 times per week until clear, \\nthen tapered. (Skin cancer development, photoaging)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Newer Biological Agents\\n- Alefacept ; Fusion protein of Fc receptor of human lgG1 and LFA3. (IM; \\nwhen effective long remissions; monitoring of CD4 q wk; slow onset)\\n- Efalizumab ; Humanized monoclonal antibody to CD11 a; blocks LFA-1/ \\nICAM interaction. (SC; rapidly effective, but rebound; risk of \\nthrombocytopenia)\\n- Etanercept ; Fusion protein directed against soluble TNFa(SC; effective for \\npsoriasis & psoriatic arthritis; rapid onset; no monitoring; use +/- MTX)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='- Infliximab ; Chimeric monoclonal antibody against TNFa (IV; Fast onset and \\nvery effective; must do PPD; infusion reactions.\\n- Adalimumab ; Fully humanized anti-TNF monoclonal antibody (SC; newest \\nof the biologics, still being studied.\\nNote TNF drugs avoid or use with caution in presence of CHF, demyelination \\ndisorders. Increased risk of opportunistic infections.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4 Scalp; 10% salicylic acid in mineral oil qhs, tar shampoo \\nqd, steroid lotion, calcipotriol lotion.\\n\\uf0a4 Nails; Intradermal triamcinolone acetonide injections \\n(painful), methotrexate, new biologics.\\n\\uf0a4 Generalized psoriasis (>10% BSA) benefits from systemic \\ntherapy, best administered by an experienced physician'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4 Acquired skin disorder characterized by well-defined \\nareas of complete epidermal depigmentation; various \\npathogenesis theories; likely a large autoimmune \\ncomponent\\n\\uf0a4 History; Asymptomatic: 50% present before age 20, 1-2% \\naffected, rare in infancy & old age\\n\\uf0a4 Associated with immune disorder; therefore workup for \\nthyroid disease, diabetes, pernicious anemia and other \\nautoimmune diseases occasionally indicated'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4 Physical: Stark white patch with well-demarcated border; \\nhair in vitiligo patches appears white or gray\\n\\uf0a4 Increased risk of sunburn and skin cancer in amelanotic\\nareas\\n\\uf0a4 Investigations; Wood’s lamp accentuates areas of vitiligo\\n& helps determine extent; consider TSH and fasting blood \\nglucose\\n\\uf0a4 DDx; Leprosy, pityriasis alba, tinea vesicolor, tuberous \\nsclerosis, nevus depigmentosus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4 Management\\n- Mainly for cosmetic, psychological burden\\n- Topical steroids and new topical immunomodulators (tacrolimus & pimecrolimus), \\nPUVA, NB-UVB, phototherapy\\n- Camouflage makeup\\n- Note that facial and more proximal lesions respond better than acral lesions\\n- Surgical transplants can be considered in stable vitiligo\\n- If extensive, can consider bleaching of nonaffected areas to result in total white \\ncolor\\n- -Advise; importance of sun protection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4 Etiology: Self-limited viral infection of skin caused by \\npoxvirus affecting mainly children.\\n\\uf0a4 Immunocompromised patients (e.g., HIV) may develop \\nmore widespread and larger lesions\\n\\uf0a4 History: Asymptomatic; occasional perilesional pruritus, \\nvery common in children. Spread by direct contact or \\nautoinoculation. Lesions tend to be more numerous and \\nspread rapidly in patients with atopic dermatits.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4 Physical: 2- to 6- mm firm, flesh colored, dome-shaped, \\numbilicated pearly papules; most common affected sites –\\ntrunk and face of children, genital/inner thigh of sexually \\nactive adults\\n\\uf0a4 Molluscum papules in a child in the periorbital region. \\nLesions can be spread by picking and scratching. Lesions \\nwill be resolve with development of cellular immunity. \\n\\uf0a4 Course: lesions typically involute spontaneously within 9-12 \\nmo; may develop adjacent eczema (10%)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4 Investigation: clinical diagnosis, biopsy if uncertain\\n\\uf0a4 DDx: BCC, milia, other infection, warts'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4 Management\\n- Observation\\n- Liquid Nitrogen Cryotherapy\\n- Curettage: may be uncomfortable\\n- Papule incision with a scalpel blades or at home sharp fingernail and expression of \\ncontents\\n- Topical cantharidin 0.7%: Blistering will occur\\n- Imiquimod cream, Tretinoin cream\\n- In children with widespread involvement, may consider oral cimetidine (40 \\nmg/kg/d ) for 2 mo.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tinea Versicolor)\\n\\uf0a4 Etiology : Common superficial cutaneous fungal infection \\ncaused by Malassezia furfur (Pityrosporum orbiculare), The \\norganism is part of normal skin\\n\\uf0a4 History : May itch but usually asymptomatic, young adults \\ntypically affected (years of higher sebaceous activity) ; \\ncommonly recurs (40-60%) ; more common in hot and humid \\nenvironments.\\n\\uf0a4 Cushing disease, pregnancy, mulnutrition, corticosteroid'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='therapy, immunosuppression, oral contraceptives may lower \\nresistance, allowing this normally non-pathogenic resident \\nyeast to poliferate'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tinea Versicolor)\\n\\uf0a4 Physical : Round to oval macules and patches on the \\ntrunk extending to the upper arms, neck, abdomen; \\ndifferent colors: White, orange-brown, dark-brown; very \\nfine scale; postinflammatory hypopigmentation is often \\nnoted rather than initial erythema.\\n\\uf0a4 Investigations: KOH test reveals diagnostic “spaghetti & \\nmeatballs” (hyphae & spores); Wood’s lamp shows \\nyellow-brown fluorescence. Skin biopsy if diagnosis \\nuncertain.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='uncertain.\\n\\uf0a4 DDx : Tinea corporis, vitiligo, psoriasis.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)\\n\\uf0a4 Management\\n\\uf0a4 Topical or systemic treatment.\\n\\uf0a4 Nizoral shampoo (ketoconazole 2%) applied onto dampened \\ntrunk skin, lathered for 5 min before rinsing, x 3 d.\\n\\uf0a4 Topical selenium sulfide 2.5% shampoo applied for 15 min x 3 d.\\n\\uf0a4 Topical nizoral cream 2% (ketoconazole) bid x 2 wk.\\n\\uf0a4 Systemic ketoconazole 200 mg po qd x 5 – 7 d or fluconazole \\n400 mg x 1. Postinflammatory hypopigmentation may persist for \\n6 – 12 mo.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='6 – 12 mo.\\n\\uf0a4 Even with treatment, tendency to recur in summer.\\n\\uf0a4 Zinc pyrithione soap lather may be applied to the body 1 – 3 \\ntimes weekly for prevention.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4 Dermatophyte digest and invade keratin then infect skin, \\nnails and hair; incubation period = 1-3 weeks\\n\\uf0a4 Trychophyton, Microsporum, Epidermophyton species \\ncommonly involved.\\n\\uf0a4 Risk Factors; Hot, humid environment, sweating or \\nmaceration of the skin, occlusive footwear, Diabetes \\nmellitus, immunosuppression\\n\\uf0a4 History: Asymptomatic; occasionally mild pruritus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4 Physical; Scalp hair and general body surfaces mostly \\naffected during childhood; hand, foot or nail infections \\nare more common after puberty\\n\\uf0a4 Immunologic response to a dermatophyte infection may \\nresult in a dermatophytid reaction: Vesicular eruption on \\nacral surfaces, especially the palms'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4 Investigations; Skin scraping analysis with KOH prep –\\nSeptate hyphae branching at various angles are seen; \\nfungal culture\\n\\uf0a4 DDx; Eczema, granuloma annulare, psoriasis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea Capitis\\n\\uf0a4 Caused by invasion of stratum corneum and hair shaft with fungal \\nhyphae.\\n\\uf0a4 Four clinical infection patterns;\\n- Seborrheic dermatitis type- Diffuse, patchy scale on scalp\\n- Black dot pattern- hyphae invade hair shaft. Hair then broke at \\nscalp surface. Broken shaft like black dots. Round area of alopecia \\nwithout inflammation\\n- Inflammation tinea capitis (kerion)- Deep boggy round masses with \\npustules, surface exudate'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='- Pustular- Pustules areas without scaling, significant hair loss may be \\npresent, look like scalp bacterial infection.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic dermatitis type – Tinea\\nCapitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Black dot pattern – Tinea Capitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Inflammation tinea capitis (kerion) –\\nTinea Capitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea Capitis\\n\\uf0a4 Management\\n- Examine sibling and household members, clean or discard \\ncontaminated objects.\\n- Griseofulvin; usually 6-12 weeks\\n- Itraconazole and fluconazole; taken for 4-8 weeks. A single dose of \\n150 mg once weekly for 4 weeks also be effective for older children\\n- Shampoo with selenium sulfide 1% or ketoconazole every other day \\nfor the first 2 weeks, then twice weekly throughout course of rest of \\noral therapy. Shampoo is left for 5 min'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='- Consider suppression kerion inflammation with prednisolone 1-2 \\nmg/kg qd or intralesional triamcinolone 10 mg/cc'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4 Common form of septal panniculitis that is usually a reactive skin response to \\nan associated trigger\\n- Infections; Bacterial (e.g., streptococcal pharyngitis), microbacterial\\n(tuberculosis)\\n- Drugs; e.g., oral contraceptives, sulfonamides\\n- Sarcoidosis\\n- Inflammatory bowel disease\\n- Behcet disease\\n- Malignancy\\n- - Pregnency'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4 History; Lesions may be associated with fever, malaise, \\nleg edema and arthralgia. Resolution after 2-6 wk\\n\\uf0a4 Physical; painful, dull, erythematous nodules 1-5 cm in \\ndiameter, located on anterior lower legs of young \\nwoman. No ulceration, discharge or scarring\\n\\uf0a4 Investigation; Through review of systems: CBC, UA, chest \\nx-ray and throat swab\\n\\uf0a4 DDx; Insect bite reaction, erysipelas, urticaria'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4 Management\\n- Investigate for and treat underlying cause.\\n- Most patients benefit from bed rest, applying ice or cool \\ncompresses, elevating legs & NSAIDs\\n- Less common Tx choice; Oral prednisolone, colchicine, \\ndapsone'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4 An inflammatory condition of degenerative collagen. \\nWhen present, it is often associated with diabetes\\n\\uf0a4 Lesions usually develop slowly and are often \\nasymptomatic, onset may occur at any age but the \\ndisease most common starts at 3rd – 4th decade. About \\n75% of those affected are women'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4 Physical Findings\\n\\uf0a4 Lesion are usually limited to the anterior shins but may be seen \\non calve and thighs, and rarely on the arms, hands, feet and \\nscalp.\\n\\uf0a4 They begin as round, violaceous patches and slowly expand. \\nThe advancing border is red, and the central area turns a \\ncharacteristic orange-yellow brown. The central area atrophies \\nand shows a shiny, waxy surface with prominent telangiectasias.\\n\\uf0a4 Ulceration may occur, particulary after trauma, in about 15% of'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='cases. These ulcers are exquisitely tender.\\n\\uf0a4 The number or severity of lesions or ulcerations has not been \\ncorrelated with the degree of diabetic control.\\n\\uf0a4 The course is unpredictable. Lesions usually heal with atrophic \\nscarring, or can be chronic and recurrent.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4 Treatment\\n\\uf0a4 Topical and intralesional steroids slow the inflammation but may \\npromote further atrophy. Middle- to high-potency \\ncorticosteroids can be used under occlusion.\\n\\uf0a4 Intralesional injections of triamcinolone acetonide 10 mg/mL \\ncanbe helpful.\\n\\uf0a4 A short course (5-6 weeks) of oral corticosteroids can be \\nconsidered if disease activity and symptoms are severse, but this \\nis rarely the case.\\n\\uf0a4 Pentoxifylline (Trental) 400mg t.i.d. has been advocated by'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='some and has been used in combination with low-dose aspirin \\nfor ulcerating necrobiosis lipoidica. \\n\\uf0a4 Skin grafting can be performed for extensive disease.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d Common idiopathic benign epidermal growth\\n\\uf07d Common in fourth decade\\n\\uf07d Males and females equally affected\\n\\uf07d More common in fair skin\\n\\uf07d Possibly autosomal dominant\\n\\uf07d Gradual development; occasionally pruritic or sore'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d Well circumscribed  epidermal growth, raised lesions\\n\\uf07d Waxy round-oval papules and plaques with verrucous or \\ncrusted surface. Sharp border\\n\\uf07d “Stuck on” appearance \\n\\uf07d Starts as light brown macule \\n larger and verrucous with \\ntime\\n\\uf07d Also, smooth-surfaced lesions contain dark or light round \\nhorn pearls embedded in the lesion or protruding from the \\nsurface. \\n\\uf07d Variably pigmented and size\\n\\uf07d Most commonly: trunk, neck, arms, scalp; wide range of size'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf0a4 Leser-Trelat sign: Sudden, eruptive seborrheic keratoses in \\nelderly individuals, often with inflammatory base may be \\na sign of an associated internal (stomach cancer & \\nothers) malignancy as part of paraneoplastic syndrome'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf0a4 Investigation: Clinical diagnosis; skin biopsy if uncertain.\\n\\uf0a4 DDx: AK, BCC, lentigo, melanoma, nevus, skin tag, wart'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d Treatment may be indicated for symptomatic lesions which \\nare inflamed, irritated or bleeding.\\n\\uf07d THERAPIES\\n◦ Cryotherapy; for flat to minimally raised lesions. \\n◦ Light cautery/electrodessication \\n◦ Shave excision\\n◦ Laser\\n\\uf096 Not effective for thicker lesions \\n\\uf096 Ruby (694nm)\\n\\uf096 Alexandrite (755nm)\\n\\uf096 CO2\\n\\uf096 Erbium'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d Most common precancerous lesions in humans, and more \\nprevalent in fair-skinned individuals who tan poorly and burn \\neasily.\\n\\uf07d Found in sun-exposed skin \\n◦ Face, ears\\n◦ Neck, forearms\\n◦ Dorsal hands\\n\\uf07d Outdoor occupations, ionizing radiation, \\nand arsenic exposure'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d Common in skin type I-III\\n\\uf07d Secondary to cumulative keratinocyte damage\\n\\uf07d Atypical keratinocytes confined to epidermal basal layer\\n\\uf07d < 1% progress to skin cancer (squamous cell carcinoma, SCC)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf0a4 Clinical appearance\\n- Slightly erythematous, rough, scaly papules on sun-exposed \\nareas\\n- May be difficult to see, but often feel rough: Palpation is \\nessential to diagnosis.\\n- Most commonly in the elderly\\n- DDx: BCC, Bowen disease, SCC\\n- Investigation: Biopsy if recurrent, unresponsive to treatment, \\nor pronounced hyperkeratosis and induration'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d Treatment options\\n◦ Topical\\n\\uf096 5%  5-flourouracil  (Carac, Efudex) applied bid for 2-4 \\nwk\\n\\uf096 5% Imiquimod (Aldara) applied three to five times \\nweekly for 12 wk\\n\\uf096 Expect \\n erythema, irritated, inflamed and crusting; \\nfollow-up visit in 1-2 wk to evaluate severity of side \\neffects'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n◦ Liquid Nitrogen Cryotherapy for limited lesions\\n◦ Electrodesication and curettage, CO2 laser\\n◦ Dermabrasion\\n◦ Chemical peel (for numerous AKs)  \\n\\uf096 Serial medium depth \\n TCA\\n◦ Light Therapy\\n\\uf096 PDT with ALA. Pulsed CO2\\nSun-awareness and protection advice'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Most common cutaneous malignancy derived from stem \\ncells of epidermis. Locally invasive, slow-growing, rarely \\nmetastasizes (unless patients is immunocompromised)\\n\\uf0a4 Etiology: Chronic UV exposure (Cumulative sun exposure \\nis primary risk factor), radiation, immunosuppression, \\ngenetics (e.g., nevoid basal cell carcinoma syndrome)\\n\\uf0a4 History: Persistent, nonhealing papule or nodule that \\nulcerates or bleeds (beefy-red smooth erosive nodule).'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Common in elderly (most common after 40) Caucasians.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Physical: Pearly papule or nodule with telangiectases, \\nrolled border; central crust or ulceration.\\n\\uf0a4 Distributed mostly on sun-exposed areas, i.e., head and \\nneck (85%). Variants: Superficial, nodular, sclerosing\\n(morpheaform), pigmented\\n\\uf0a4 DDx: Melanoma, nevus, SCC\\n\\uf0a4 Investigations: Biopsy must be performed to confirm \\ndiagnosis and classify subtype.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Physical Findings\\n- Nodular BCC: Most common variant. A pearly white, \\nalmost translucent, dome-shaped papule with overlying \\ntelangiectasias. Papule or nodule enlarges slowly, may \\nbecome flattened in center or may develop a raised, rolled, \\ntranslucent border. Frequently ulcerates, bleeds, becomes \\ncrusted in center'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n- Pigmented BCC: contains melanin, may therefore \\nresemble melanoma\\n- Superficial BCC: least aggressive form. More commonly \\non trunk, extremities. Circumscribed, round to oval, red, \\nscaling plaque resembles eczema, psoriasis, \\nextramammary Paget disease or Bowen disease\\n- Sclerosing BCC : Most subtle and least common variant. \\nSmooth, pale white to yellow papules. Resembles scar \\ntissue. Borders may be difficult to discern. Higher rate of \\nrecurrence'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nNodular BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nPigmented BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nSuperficial BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nSclerosing BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Management\\n- Advise that metastases and death are extremely rare. Vast \\nmajority cause no major problem, but should be treated\\n- Without treatment, BCCs persist, enlarge, ulcerate, invade, \\ndestroy surrounding structures \\n- Tx options depend on histological subtype and location: \\nLiquid nitrogen cryotherapy (requires experience), \\ncurettage & electrodessication (most common Tx), excision, \\nMohs micrographic surgery, imiquimod cream for superficial'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='subtype, 5-FU, CO2 laser, radiation therapy\\n- Advise on sun protection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Electrosurgery of obvious tumor. The 5 year cure rate \\napproach 92%\\n\\uf0a4 Primary excision is preferred for non-facial, well-defined \\nnodular. The 5 year rate approach 90%\\n\\uf0a4 Mohs microsurgery is a highly specialized, tissue-sparing \\nmethod of excision used for difficult tumors with \\ncontiguous growth. It is also used for recurrent BCC, \\nhistological  aggressive forms of BCC, such as sclerotic \\nBCCs, and tumors in anatomically important locations'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='such as around eyes, nasal alar, mouth and ears.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4 Radiation therapy may be useful for difficult-to-treat \\ntumors, such as eyelids, and for patients unable to \\ntolerate surgery. The 5 year cure rates are roughly 90%\\n\\uf0a4 Photodynamic therapy is an evolving chemotherapeutic \\nmodality for superficial BCC\\n\\uf0a4 Topical imiquimod 5% cream is an immune response \\nmodifier shown to be about 85% effective or better for \\nsuperficial BCC. It is less effective for nodular BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n2nd most common form of skin cancer (after BCC) arising in sun \\nexposed areas in elderly; due to malignant keratinocytes with \\nmetastatic potential.\\n\\uf0a4 Etiology : Chronic UV-damage is the primary cause, \\nimmunosuppression, burns leg ulcers, chemical carcinogens \\n(e.g., tar), HPV; can occur in discoid lupus, lichen sclerosus, \\n& any scarring processes.\\n\\uf0a4 History : Slow-growing, nonhealing scaly papule on sun-\\nexposed area of head, neck, dorsal hands, and forearms;'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='also affects mucous membranes (lower lip: M >> F, smokers, \\n10% - 15% metastatic rare); rare in dark skin.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n\\uf0a4 Physical : Firm indurated papule, plaque, or nodule with \\nadherent rough scale on sun-exposed areas. Normally with \\nnecrotic crusted center. Removal of crust reveals central \\ncavity filled with necrotic keratin debris.\\n\\uf0a4 Actinic keratosis is considered a precursor lesion; actinic \\ncheilitis is the precursor on lip.\\n\\uf0a4 Ultimately, tumors metastasize, via the lymphatics to other \\norgans\\n\\uf0a4 Investigations : Biopsy (to mid-dermis) for confirmation.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4 DDx : AK, BCC, SK, amelanotic melanoma, wart.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n\\uf0a4 Management\\n\\uf0a4 Wide local excision with histologic confirmation of margins.\\n\\uf0a4 Lymp node biopsy indicated for suspected nodal disease\\n\\uf0a4 Liquid nitrogen cryotherapy\\n\\uf0a4 Mohs micrographic surgery\\n\\uf0a4 Less commonly topical imiquimod or radiation\\n\\uf0a4 Advide on sun protection.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4 Etiology : Melanocyte-derived skin cancer. May arise within \\na previously existing nevus or dysplastic nevus, but ~ 70% \\narise de novo \\n\\uf0a4 History : Risk factors\\n\\uf0a4 Fair complexion: Red/blonde hair, blue/green eyes, tendency to \\nfreckle and burn.\\n\\uf0a4 Sun exposure, particularly blistering sunburns during childhood.\\n\\uf0a4 Personal of family history of melanoma; Genes involved in some \\ncases: CDKN2A, BRAF.\\n\\uf0a4 Giant congenital melanocytic nevi or multiple dysplastic nevi.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4 Physical: Pigmented macule or plaque with some or all of the \\nfollowing features \\nABCDE of melanoma: \\n- Asymmetry\\n- Borders (irregular)\\n- Color variegation\\n- Diameter (> 6mm)\\n- Evolution (lesion change by history)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\nClassically divided into subtypes based on clinical and histopathologic features:\\n1. Superficial spreading malignant melanoma – 60%-70% of melanomas.\\n2. Nodular melanoma.\\n3. Acral-lentiginous melanoma – Most common form in blacks, Asians, and \\nHispanics, mostly on volar skin of the palms or soles and the nailbeds.\\n4. Lentigo maligna melanoma – Develops from a lentigo maligna, usually on the \\nface of elderly, slow-growing.\\n5. Amelanotic melanoma – Pink-red.\\n6. Rare variants.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Superficial spreading malignant \\nmelanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Nodular melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acral-lentiginous melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lentigo maligna melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Amelanotic melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4 Most common sites of local and/or regional metastases-\\nDraining lymph node basins and the skin between the \\nprimary site and the lymph nodes.\\n- Most common sites of systemic metastases – Lung, Liver, \\nbrain (#1 cause of death), bone, and gastrointestinal tract. \\n\\uf0a4 Investigations: Dermoscopy (ABCD rule), excisional biopsy if \\nmelanomais suspected\\n\\uf0a4 Most important prognostic indicator is maximal thickness of \\ntumor invasion on biopsy (Breslow depth in mm)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4 DDx: BCC, blue or dysplastic nevus, SK'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4 Management\\n- Wide surgical excision; based on Breslow depth: 5 mm for \\nmelanoma in situ, 1 cm for melanoma <1mm, 2 cm for \\nmelanoma >1mm\\n- Sentinel lymph node biopsy depending on clinical\\n- Adjuvant high-dose interferon & IL-2 may provide benefit for \\nmetastatic disease\\n- Perfusion chemotherapy for extremity melanoma\\n- Radiation'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 Chronic inflammatory dermatosis affecting 10%-20% of \\nchildren (esp. infants and young children)\\n\\uf0a4 Etiology: Cutaneous immune dysfunction; IgE-mediated; \\ngenetics. Strong associated with personal and family \\nhistory of atopy (eczema, asthma)\\n\\uf0a4 History: “Pruritus” is a hallmark (“the itch that rashes”). \\nAggravating factors: sweating, contact sensitivity, \\nsecondary infection, wool, food allergy, stress/anxiety.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 Acute: Erythematous, excoriated, scaling patches and plaques; \\nmore lichenification in chronic forms.\\n\\uf0a4 Distribution:\\n- Infants: Cheeks, forehead, scalp, extensor surfaces of extremities\\n- Child: Flexural surfaces- antecubital and popliteal fossae, wrists, \\nankles\\n- Adults: Hands, flexural. The prominent finding is lichenification; this \\nindicates a long – standing problem.\\n\\uf0a4 Lesions can be secondarily infected with staphylococcal \\norganisms: impetigo'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nInfants: Cheeks, forehead, scalp, extensor surfaces of extremities'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nChild: Flexural surfaces- antecubital and popliteal fossae, wrists, ankles'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nAdults: Hands, flexural. The prominent finding is lichenification\\n; this indicates a long – standing problem'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 DDx: Contact dermatitis, psoriasis, seborrheic dermatitis\\n\\uf0a4 Investigation: Allergy or RAST testing of little value (Patch \\ntest if dermatitis pattern changes or refractory to \\ntreatment. \\n\\uf0a4 Diagnosis Requires: History of an itchy skin condition (or \\nparental report of scratching/rubbing by the child)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 Plus ≥3 of :\\n1. History of involvement of skin crease (antecubital, popliteal, anterior \\nankles or around the neck) or cheeks in children < 10 years\\n2. Personal history of asthma or hay fever (or history of atopic disease \\nin 1st degree relative if < 4 years of age)\\n3. History of generalized dry skin in the past year.\\n4. Visible flexural dermatitis (or eczema on the cheeks/forehead and \\nouter limbs in children < age 4 years)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='5. Onset under the age of 2 (do not use as criterion if patient is < age 4 \\nyears)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 Minor, less specific feature: \\n- xerosis, ichthyosis, palmar hyperlinearity, keratosis pilaris. \\nImmediate type 1 skin test responses, dermatitis of hands \\nand feet, cheilitis, nipple eczema, increased susceptibility to \\ncutaneous infection, perifollicular accentuation'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4 Management\\n- Elimination of precipitating irritants: avoid wool and synthetic \\nfabrics; wear cotton clothes, humidifier at home; dietary \\nrestriction if specific verified food allergy; stress reduction.\\n- Skin hydration: Baths with emollients, apply thick \\nnonfragranced emollient immediately after bath.\\n- Topical steroids: 1% hydrocortisone ointment bid to face \\nand folds, midpotency steroids bid to other effected areas;'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='ointments more occlusive and more effective than creams.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4 Management\\n- Steroid-sparing topical immunomodulators can be used bid in \\nchildren > 2 yr: Pimecrolimus cream – mild to moderate eczema. \\nTacrolimus – moderate to severe eczema.\\n- Oral antihistamines with sedative effect may offer symptomatic \\nrelief of the associated pruritus, e.g., hydroxyzine (3-5 mg/kg/d divided \\ntid/qid)\\n- If secondarily infected: antibiotic therapy\\n- If patients refractory to conventional therapy, other systemic Tx'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='choices include: PUVA or UVB light therapy, systemic steroids (short \\ncourses), methotrexate, cyclosporine: usually administered by \\ndermatologist')]"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_chunk"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "54f17d3c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "139"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(text_chunk)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "14c5c00f",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.embeddings import HuggingFaceBgeEmbeddings\n",
    "\n",
    "def download_embeddings():\n",
    "    model_name=\"sentence-transformers/all-MiniLM-L6-v2\"\n",
    "    embeddings=HuggingFaceBgeEmbeddings(model_name=model_name)\n",
    "    return embeddings    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "68350b41",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Manodya\\AppData\\Local\\Temp\\ipykernel_29836\\1364964222.py:5: LangChainDeprecationWarning: The class `HuggingFaceBgeEmbeddings` was deprecated in LangChain 0.2.2 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-huggingface package and should be used instead. To use it run `pip install -U :class:`~langchain-huggingface` and import as `from :class:`~langchain_huggingface import HuggingFaceEmbeddings``.\n",
      "  embeddings=HuggingFaceBgeEmbeddings(model_name=model_name)\n"
     ]
    }
   ],
   "source": [
    "embedding=download_embeddings()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "6afcb6e4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "HuggingFaceBgeEmbeddings(client=SentenceTransformer(\n",
       "  (0): Transformer({'max_seq_length': 256, 'do_lower_case': False}) with Transformer model: BertModel \n",
       "  (1): Pooling({'word_embedding_dimension': 384, 'pooling_mode_cls_token': False, 'pooling_mode_mean_tokens': True, 'pooling_mode_max_tokens': False, 'pooling_mode_mean_sqrt_len_tokens': False, 'pooling_mode_weightedmean_tokens': False, 'pooling_mode_lasttoken': False, 'include_prompt': True})\n",
       "  (2): Normalize()\n",
       "), model_name='sentence-transformers/all-MiniLM-L6-v2', cache_folder=None, model_kwargs={}, encode_kwargs={}, query_instruction='Represent this question for searching relevant passages: ', embed_instruction='', show_progress=False)"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "embedding"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "21afd48d",
   "metadata": {},
   "outputs": [],
   "source": [
    "vector=embedding.embed_query(\"Hello world\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "ecdf0904",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "vector length: 384\n"
     ]
    }
   ],
   "source": [
    "print(\"vector length:\",len(vector))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "52a049cf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from dotenv import load_dotenv\n",
    "import os \n",
    "load_dotenv()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "6bbcea1d",
   "metadata": {},
   "outputs": [],
   "source": [
    "OPENAI_API_KEY=os.getenv(\"OPENAI_API_KEY\")\n",
    "PINECONE_API_KEY=os.getenv(\"PINECONE_API_KEY\")\n",
    "\n",
    "os.environ[\"OPENAI_API_KEY\"]=OPENAI_API_KEY\n",
    "os.environ[\"PINECONE_API_KEY\"]=PINECONE_API_KEY"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "98a15114",
   "metadata": {},
   "outputs": [],
   "source": [
    "from pinecone import Pinecone\n",
    "pinecone_api_key=PINECONE_API_KEY\n",
    "\n",
    "pc=Pinecone(api_key=pinecone_api_key)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "454b550a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<pinecone.pinecone.Pinecone at 0x2b19b5be120>"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "6c2539c5",
   "metadata": {},
   "outputs": [],
   "source": [
    "from pinecone import ServerlessSpec\n",
    "\n",
    "index=\"medi-bot\"\n",
    "if not pc.has_index(index):\n",
    "    pc.create_index(\n",
    "        name=index,\n",
    "        dimension=384,\n",
    "        metric= \"cosine\" ,#cosine  similarity,\n",
    "        spec=ServerlessSpec(cloud=\"aws\",region=\"us-east-1\") #specification\n",
    "    )\n",
    "index=pc.Index(index)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "1ff37356",
   "metadata": {},
   "outputs": [],
   "source": [
    "# index already initialized above; don't call pc.Index twice\n",
    "# No-op to avoid TypeError when re-running the cell\n",
    "pass"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "d906b7e4",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_pinecone import PineconeVectorStore\n",
    "\n",
    "# Use the index name string so the LangChain wrapper can locate the existing index\n",
    "# and avoid passing an Index object or None accidentally.\n",
    "doc_to_vector = PineconeVectorStore.from_documents(\n",
    "    documents=text_chunk,\n",
    "    embedding=embedding,\n",
    "    index_name=\"medi-bot\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "8df79d4d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{\n",
      "    \"name\": \"medi-bot\",\n",
      "    \"metric\": \"cosine\",\n",
      "    \"host\": \"medi-bot-1oa1xua.svc.aped-4627-b74a.pinecone.io\",\n",
      "    \"spec\": {\n",
      "        \"serverless\": {\n",
      "            \"cloud\": \"aws\",\n",
      "            \"region\": \"us-east-1\"\n",
      "        }\n",
      "    },\n",
      "    \"status\": {\n",
      "        \"ready\": true,\n",
      "        \"state\": \"Ready\"\n",
      "    },\n",
      "    \"vector_type\": \"dense\",\n",
      "    \"dimension\": 384,\n",
      "    \"deletion_protection\": \"disabled\",\n",
      "    \"tags\": null\n",
      "}]\n"
     ]
    }
   ],
   "source": [
    "print(pc.list_indexes())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "d036db8c",
   "metadata": {},
   "outputs": [],
   "source": [
    "#add more data to the exsisting pinecone index"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "ffe64f30",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['4bd078d1-05b7-4875-84ea-2531cf64c783']"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "new_doc=Document(\n",
    "    page_content=\"this is my new project\",\n",
    "    metadata={\"source\":\"skin diseases\"}\n",
    ")\n",
    "\n",
    "doc_to_vector.add_documents([new_doc])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "036f23c9",
   "metadata": {},
   "outputs": [],
   "source": [
    "retriever=doc_to_vector.as_retriever(\n",
    "    search_type=\"similarity\",\n",
    "    search_kwargs={\"k\":3}\n",
    "    \n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "0c583fc1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(id='f36f1edf-68cc-483b-8e9b-d3dc6e211e98', metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne Vulgaris\\n\\uf0a4 4 Major components\\n• Abnormal follicular keratinization: follicular wall cells fail to \\ndesquamate to the surface in the normal manner.\\n• Sebum over production secondary to androgen\\n• Propionibacterium acnes infection; they grow in the \\nsebum-cell mixture.\\n\\uf0a7 Inflammation\\n\\uf0a4 Other components; genetic factors, occlusive cosmetic \\nagents, medication (steroids, ACTH, androgens, lithium, \\nantiepileptics, oral contraceptives), diseases (PCOS, \\nCongenital Adrenal Hyperplasia)'),\n",
       " Document(id='36400497-ff9d-483c-b079-c289bb09bac5', metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne Vulgaris\\n\\uf0a4 Inflammatory disorder of pilosebaceous follicle with a 90% \\nprevalence in adolescence and young adulthood.\\n\\uf0a4 History: often asymptomatic lesions (especially comedone), \\nalthough can be tender (nodules)\\n\\uf0a4 Physical: two types of lesions, predominantly affect face, \\nneck, chest and back\\n- Noninflammatory; open(“black head”) and closed (“white \\nhead”) comedones\\n- Inflammatory; papules, pustule, cysts, nodule: deep lesions \\n(leave scars)'),\n",
       " Document(id='9dc85a18-21c6-4425-9994-ef23890f0096', metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nTreatment Strategies\\n- Retinoid for clearing pores and comedones for all acne \\nconditions\\n- Small inflammatory lesions \\uf0e0Topical Benzoyl Peroxide (BP) &  \\nTopical Antibiotic\\n- Large inflammatory lesions \\uf0e0 Oral antibiotic')]"
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "retrieved=retriever.invoke(\"what is acne?\")\n",
    "retrieved"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "ec9e1974",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_openai import ChatOpenAI\n",
    "chat_model=ChatOpenAI(\n",
    "    model=\"gpt-4o\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "cb15f7e4",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.chains import create_retrieval_chain\n",
    "from langchain.chains.combine_documents import create_stuff_documents_chain\n",
    "from langchain_core.prompts import ChatPromptTemplate"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "a1a5373b",
   "metadata": {},
   "outputs": [],
   "source": [
    "system_prompt=(\n",
    "   \"you are a medical chatbot.\"\n",
    "   \"use the following retrieved context to answer.\"\n",
    "   \"if you do not know the answer say thta you do not know\"\n",
    "\"if you know the answer provide three sentences with maximum similarities\"\n",
    "\"\\n\\n\"\n",
    "\"{context}\"\n",
    ")\n",
    "\n",
    "\n",
    "prompt=ChatPromptTemplate.from_messages(\n",
    "    [\n",
    "        (\"system\",system_prompt),\n",
    "        (\"human\",\"{input}\")\n",
    "    ]\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "bceb2047",
   "metadata": {},
   "outputs": [],
   "source": [
    "question_answer_chain=create_stuff_documents_chain(chat_model,prompt)\n",
    "rag_chain=create_retrieval_chain(retriever,question_answer_chain)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "d72e50b9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rosacea is a skin condition predominantly affecting the central face, including areas like the forehead, cheeks, nose, chin, and sometimes the eyelids. It is diagnosed clinically, but a skin biopsy may be used to rule out conditions like lupus or sarcoidosis. Common differential diagnoses include acne, lupus erythematosus, sarcoidosis, seborrheic dermatitis, and perioral dermatitis.\n"
     ]
    }
   ],
   "source": [
    "response=rag_chain.invoke({\"input\":\"what is rosacea?\"})\n",
    "print(response[\"answer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "698b8988",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rosacea treatment is based on severity and subtype, but typically it includes lifestyle modifications such as avoiding triggers and sun protection. Topical antibiotics like Metronidazole 0.75% gel or 1% cream, and Sodium sulfacetamide lotion 10% are commonly used. Azelaic acid is also recommended for once-daily application.\n"
     ]
    }
   ],
   "source": [
    "response=rag_chain.invoke({\"input\":\"what are the treatments for  rosacea?\"})\n",
    "print(response[\"answer\"])"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "medibot (3.12.0)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
